Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Bladder Cancer, January 2020 Free Subscription Abstracts Retrieve all available abstracts of the following 606 articles: HTML format

Single Articles

1. DYER T, Siemens DR, Nippak P, Meyer J, et al
   Histology at transurethral resection of bladder tumor and radical cystectomy for bladder cancer: Insights from population-based data.
   Can Urol Assoc J. 2020 Sep 28. pii: cuaj.6856. doi: 10.5489/cuaj.6856.
   Abstract     Related articles   
   
   
2. SOMUNCU B, Keskin S, Antmen FM, Saglican Y, et al
   Non-muscle invasive bladder cancer tissues have increased base excision repair capacity.
   Sci Rep. 2020;10:16371.
   Abstract     Related articles   
   
   
3. VALENBERG FJPV, Hiar AM, Wallace E, Bridge JA, et al
   Validation of an mRNA-based Urine Test for the Detection of Bladder Cancer in Patients with Haematuria.
   Eur Urol Oncol. 2020 Sep 28. pii: S2588-9311(20)30141.
   Abstract     Related articles   
   
   
4. KUBON J, Sikic D, Eckstein M, Weyerer V, et al
   Analysis of CXCL9, PD1 and PD-L1 mRNA in Stage T1 Non-Muscle Invasive Bladder Cancer and Their Association with Prognosis.
   Cancers (Basel). 2020;12.
   Abstract     Related articles   
   
   
5. ZHOU X, Chen Y, Wang F, Wu H, et al
   Artesunate induces autophagy dependent apoptosis through upregulating ROS and activating AMPK-mTOR-ULK1 axis in human bladder cancer cells.
   Chem Biol Interact. 2020 Sep 28:109273. doi: 10.1016/j.cbi.2020.109273.
   Abstract     Related articles   
   
   
6. LYU ZJ, Wang Y, Huang JL, Chen M, et al
   Recurrent ZNF83-E293V Mutation Promotes Bladder Cancer Progression through the NF-kappaB Pathway via Transcriptional Dysregulation of S100A8.
   Mol Ther. 2020 Sep 5. pii: S1525-0016(20)30461.
   Abstract     Related articles   
   
   
7. HE H, Wu S, Ai K, Xu R, et al
   LncRNA ZNF503-AS1 acts as a tumor suppressor in bladder cancer by up-regulating Ca(2+) concentration via transcription factor GATA6.
   Cell Oncol (Dordr). 2020 Oct 1. pii: 10.1007/s13402-020-00563.
   Abstract     Related articles   
   
   
8. LI S, Jia Y, Yu C, Xiao H, et al
   Influences of Different Operative Methods on the Recurrence Rate of Non-Muscle-Invasive Bladder Cancer.
   Urol J. 2020 Oct 1:5965. doi: 10.22037/uj.v16i7.5965.
   Abstract     Related articles   
   
   
9. XU Z, Gan G, Chen G, Wu G, et al
   A Systematic Review and Meta- Analysis of Green-Light Laser Vaporization for Superficial Bladder Cancer.
   Urol J. 2020 Sep 30. pii: 5854. doi: 10.22037/uj.v16i7.5854.
   Abstract     Related articles   
   
   
10. XU G, Yang H, Liu M, Niu J, et al
    lncRNA TINCR facilities bladder cancer progression via regulating miR7 and mTOR.
    Mol Med Rep. 2020;22:4243-4253.
    Abstract     Related articles   
    
    
11. FIAZ S, Ali A, Adnan S, Khalil MAI, et al
    Comparison of Outcomes Between Radical Radiotherapy and Radical Cystectomy in Muscle Invasive Bladder Cancer in a Cancer Specialized Unit of a Developing Country.
    Cureus. 2020;12:e10057.
    Abstract     Related articles   
    
    
12. ROUANNE M, Gaillard F, Meunier M, Soorojebally Y, et al
    Measured glomerular filtration rate (GFR) significantly and rapidly decreases after radical cystectomy for bladder cancer.
    Sci Rep. 2020;10:16145.
    Abstract     Related articles   
    
    
13. CHEN M, Xu Y, Xu J, Chancoco H, et al
    Leukocyte telomere length and bladder cancer risk: a large case control study and Mendelian randomization analysis.
    Cancer Epidemiol Biomarkers Prev. 2020 Sep 30. pii: 1055-9965.EPI-20-0351.
    Abstract     Related articles   
    
    
14. SCHUETTFORT VM, Pradere B, Quhal F, Mostafaei H, et al
    Incidence and outcome of salvage cystectomy after bladder sparing therapy for muscle invasive bladder cancer: a systematic review and meta-analysis.
    World J Urol. 2020 Sep 29. pii: 10.1007/s00345-020-03436.
    Abstract     Related articles   
    
    
15. LIANG Y, Wang Y, Wang L, Liang Z, et al
    Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer.
    Bioact Mater. 2020;6:433-446.
    Abstract     Related articles   
    
    
16. BATUR AF, Aydogan MF, Kilic O, Korez MK, et al
    Comparison of De Ritis Ratio and Other Systemic Inflammatory Parameters for the Prediction of Prognosis of Patients with Transitional Cell Bladder Cancer.
    Int J Clin Pract. 2020 Sep 29:e13743. doi: 10.1111/ijcp.13743.
    Abstract     Related articles   
    
    
17. YU G, Zhou H, Xu K, Meng L, et al
    [Mir-29c-3p targeting TUG1 affects migration and invasion of bladder cancer cells by regulating CAPN7 expression].
    Nan Fang Yi Ke Da Xue Xue Bao. 2020;40:1325-1331.
    Abstract     Related articles   
    
    
18. CAO Y, Xu K, Chen B, Wang Y, et al
    [Expression of DNMT3b in human bladder cancer tissue and its correlation with clinical prognosis].
    Nan Fang Yi Ke Da Xue Xue Bao. 2020;40:1295-1300.
    Abstract     Related articles   
    
    
19. AYYILDIZ V, Aydin F, Baspinar S, Ogul H, et al
    Massive penile metastasis of bladder cancer.
    Br J Hosp Med (Lond). 2020;81:1.
    Abstract     Related articles   
    
    
20. DU Q, Chen J
    SNHG1 promotes proliferation, migration and invasion of bladder cancer cells via the PI3K/AKT signaling pathway.
    Exp Ther Med. 2020;20:110.
    Abstract     Related articles   
    
    
21. SHI MJ, Meng XY, Fontugne J, Chen CL, et al
    Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer.
    Genome Med. 2020;12:85.
    Abstract     Related articles   
    
    
22. SUGIYAMA K, Imamura M, Fujimoto T, Chihara I, et al
    [A Case of Bladder Cancer Treated with Arterial Stent-Grafting to Prevent Uretero-Arterial Fistula Due to Radiation Therapy for Metastasis].
    Hinyokika Kiyo. 2020;66:319-321.
    Abstract     Related articles   
    
    
23. OTA H, Yamaguchi T, Tsuruta M, Fuchigami Y, et al
    [A Case of Small Cell Carcinoma of the Bladder].
    Hinyokika Kiyo. 2020;66:313-317.
    Abstract     Related articles   
    
    
24. SIEVERINK CA, Batista RPM, Prazeres HJM, Vinagre J, et al
    Clinical Validation of a Urine Test (Uromonitor-V2((R))) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients.
    Diagnostics (Basel). 2020;10.
    Abstract     Related articles   
    
    
25. HAN L, Gallan AJ, Steinberg GD, Sweis RF, et al
    Morphological Correlation of Urinary Bladder Cancer Molecular Subtypes in Radical Cystectomies.
    Hum Pathol. 2020 Sep 25. pii: S0046-8177(20)30182.
    Abstract     Related articles   
    
    
26. MCFERRIN C, Davaro F, May A, Raza S, et al
    Trends in utilization of neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer.
    Investig Clin Urol. 2020 Sep 8. pii: 61.e60. doi: 10.4111/icu.20200132.
    Abstract     Related articles   
    
    
27. ALSHYARBA MH, Alamri A, Assiri AA
    Economic impacts of the Bacillus Calmette-Guerin (BCG) therapy shortage and the proposed solutions for patients with non-muscle invasive bladder Cancer in Aseer Province, Saudi Arabia.
    J Family Med Prim Care. 2020;9:2758-2762.
    Abstract     Related articles   
    
    
28. HIROTSU Y, Yokoyama H, Amemiya K, Hagimoto T, et al
    Genomic Profiling Identified ERCC2 E606Q Mutation in Helicase Domain Respond to Platinum-Based Neoadjuvant Therapy in Urothelial Bladder Cancer.
    Front Oncol. 2020;10:1643.
    Abstract     Related articles   
    
    
29. ADNAN S, Khalil MAI, Fiaz S, Abu Bakar M, et al
    Oncological Outcomes of Non-Urothelial Bladder Cancers in a Specialized Cancer Hospital of a Developing Country.
    Cureus. 2020;12:e9957.
    Abstract     Related articles   
    
    
30. OSTERMAN CK, Milowsky MI
    New and Emerging Therapies in the Management of Bladder Cancer.
    F1000Res. 2020;9.
    Abstract     Related articles   
    
    
31. WU Y, Liu Y, He A, Guan B, et al
    Identification of the Six-RNA-Binding Protein Signature for Prognosis Prediction in Bladder Cancer.
    Front Genet. 2020;11:992.
    Abstract     Related articles   
    
    
32. JIAO F, Sun H, Yang Q, Sun H, et al
    Identification of FADS1 Through Common Gene Expression Profiles for Predicting Survival in Patients with Bladder Cancer.
    Cancer Manag Res. 2020;12:8325-8339.
    Abstract     Related articles   
    
    
33. YUAN B, Sun R, Du Y, Jia Z, et al
    STAT3-Induced Upregulation of lncRNA CASC9 Promotes the Progression of Bladder Cancer by Interacting with EZH2 and Affecting the Expression of PTEN.
    Onco Targets Ther. 2020;13:9147-9157.
    Abstract     Related articles   
    
    
34. CHEN C, Liu X, Jiang J, Li S, et al
    Matrix Metalloproteinase 11 is a Potential Biomarker in Bladder Cancer Diagnosis and Prognosis.
    Onco Targets Ther. 2020;13:9059-9069.
    Abstract     Related articles   
    
    
35. LU Y, Shao J, Shu X, Jiang Y, et al
    FADS1 is a Prognostic Biomarker in Bladder Cancer: A Study Based on TCGA Data.
    Comb Chem High Throughput Screen. 2020 Sep 24. pii: CCHTS-EPUB-110227.
    Abstract     Related articles   
    
    
36. HO CY, Chang AC, Hsu CH, Tsai TF, et al
    Miconazole induces protective autophagy in bladder cancer cells.
    Environ Toxicol. 2020 Sep 27. doi: 10.1002/tox.23024.
    Abstract     Related articles   
    
    
37. REESINK DJ, van de Garde EMW, Peters BJM, van der Nat PB, et al
    Treatment patterns and clinical outcomes of chemotherapy treatment in patients with muscle-invasive or metastatic bladder cancer in the Netherlands.
    Sci Rep. 2020;10:15822.
    Abstract     Related articles   
    
    
38. TABER A, Christensen E, Lamy P, Nordentoft I, et al
    Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis.
    Nat Commun. 2020;11:4858.
    Abstract     Related articles   
    
    
39. ZHOU X, Qiu S, Nie L, Jin D, et al
    Classification of Muscle-Invasive Bladder Cancer Based on Immunogenomic Profiling.
    Front Oncol. 2020;10:1429.
    Abstract     Related articles   
    
    
40. SARKIS J, Samaha R, Kattan J, Sarkis P, et al
    Bladder cancer during the COVID-19 pandemic: the calm before the storm?
    Future Sci OA. 2020;6:FSO615.
    Abstract     Related articles   
    
    
41. ZENG M, Su Y, Li K, Jin D, et al
    Gallic Acid Inhibits Bladder Cancer T24 Cell Progression Through Mitochondrial Dysfunction and PI3K/Akt/NF-kappaB Signaling Suppression.
    Front Pharmacol. 2020;11:1222.
    Abstract     Related articles   
    
    
42. LI WX, Zhang YL
    Novel Long Non-coding RNA Markers for Prognostic Prediction of Patients with Bladder Cancer.
    Chin Med Sci J. 2020;35:239-247.
    Abstract     Related articles   
    
    
43. PARK BS, Cho SH, Kim SJ, Kim TU, et al
    Synchronous quadruple colon cancer with two lesions previously obscured by ischemic colitis, plus bladder cancer and thymoma: a case report.
    Ann Coloproctol. 2020 Sep 18. pii: ac.2020.06.18. doi: 10.3393/ac.2020.
    Abstract     Related articles   
    
    
44. MORI K, Miura N, Mostafaei H, Quhal F, et al
    Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis.
    Int J Clin Oncol. 2020;25:1459-1474.
    Abstract     Related articles   
    
    
45. CURLEY M, Bhardwaj H
    Disseminated Bacillus Calmette-Guerin Infection Detected on FDG PET/CT Following Intravesical Bacillus Calmette-Guerin Therapy.
    Clin Nucl Med. 2020 May 19. doi: 10.1097/RLU.0000000000003046.
    Abstract     Related articles   
    
    
46. CHAWLA J, Selhi PK, Narang V, Sood N, et al
    Synchronous high-grade bladder carcinoma associated with chronic lymphocytic leukemia: A rare entity in Indian literature.
    J Cancer Res Ther. 2020;16:180-182.
    Abstract     Related articles   
    
    
47. BANKHEAD A 3RD, McMaster T, Wang Y, Boonstra PS, et al
    TP63 isoform expression is linked with distinct clinical outcomes in cancer.
    EBioMedicine. 2020;51:102561.
    Abstract     Related articles   
    
    
48. SCHERZER ND, Greenberg JW, Shaw EJ, Silberstein JL, et al
    Robotic vs. open surgical management of ureteroenteric anastomotic strictures: technical modifications to enhance success.
    J Robot Surg. 2020;14:615-619.
    Abstract     Related articles   
    
    
49. MIGUEL CM, Kosinski KE, Fazzari MJ, Kongnyuy M, et al
    Pathologic measures of quality compare favorably in patients undergoing robot-assisted radical cystectomy to open cystectomy cohorts: a National Cancer Database analysis.
    J Robot Surg. 2020;14:609-614.
    Abstract     Related articles   
    
    
50. SIDDEEK RAT, Gupta A, Gupta S, Goyal B, et al
    Evaluation of platelet distribution width as novel biomarker in gall bladder cancer.
    J Carcinog. 2020;19:5.
    Abstract     Related articles   
    
    
51. SRI D, Lee HJ, El-Gemmal S, Backhouse C, et al
    Cystectomy outcomes in patients who have failed Radiofrequency-induced Thermo-chemotherapeutic Effect Mitomycin-C (RITE-MMC) treatment for high-risk non-muscle invasive bladder cancer (HRNMIBC)-Does it complicate surgery and adversely impact oncologic
    Urol Oncol. 2020 Oct 5. pii: S1078-1439(20)30438.
    Abstract     Related articles   
    
    
52. CARANDO R, Afferi L, Marra G, Krajewski W, et al
    The effectiveness of multiparametric magnetic resonance imaging in bladder cancer (Vesical Imaging-Reporting and Data System): A systematic review.
    Arab J Urol. 2020;18:67-71.
    Abstract     Related articles   
    
    
53. HURLE R, Maccagnano C
    Active surveillance for recurrent low-grade non-muscle-invasive bladder cancer: Can we take any advantage from the COVID-19 crisis?
    Arab J Urol. 2020;18:65-66.
    Abstract     Related articles   
    
    
54. WANG Z, Tang H, Xue Y, Xue L, et al
    Clinical application of drug sensitive gene detection in postoperative instillation for non-muscle invasive bladder cancer.
    BMC Nephrol. 2020;21:426.
    Abstract     Related articles   
    
    
55. LE GOUX C, Vacher S, Schnitzler A, Barry Delongchamps N, et al
    Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancer.
    Sci Rep. 2020;10:16641.
    Abstract     Related articles   
    
    
56. OLKHOV-MITSEL E, Hodgson A, Liu SK, Vesprini D, et al
    Can immune markers help identify fast relapse in patients with muscle invasive bladder cancer?
    Pathol Res Pract. 2020;216:153200.
    Abstract     Related articles   
    
    
57. MOSCHINI M, Afferi L, Gandaglia G, D'Andrea D, et al
    Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer.
    Eur Urol Focus. 2020 Oct 2. pii: S2405-4569(20)30268.
    Abstract     Related articles   
    
    
58. BEDNOVA O, Leyton JV
    Targeted Molecular Therapeutics for Bladder Cancer-A New Option beyond the Mixed Fortunes of Immune Checkpoint Inhibitors?
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   
    
    
59. DU L, Zhang L, Sun F
    Puerarin Inhibits the Progression of Bladder Cancer by Regulating circ_0020394/miR-328-3p/NRBP1 Axis.
    Cancer Biother Radiopharm. 2020 Oct 5. doi: 10.1089/cbr.2019.3382.
    Abstract     Related articles   
    
    
60. LI R, Zheng JZ, Huang X
    Suppression of HAX-1 induced by miR-325 resensitizes bladder cancer cells to cisplatin-induced apoptosis.
    Eur Rev Med Pharmacol Sci. 2020;24:9303-9314.
    Abstract     Related articles   
    
    
61. HUNT A, Hanson I, Dunlop A, Barnes H, et al
    Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer.
    Clin Transl Radiat Oncol. 2020;25:46-51.
    Abstract     Related articles   
    
    
62. VAN HEMELRIJCK M, Patel P, Mouw KW
    Editorial: Bladder Cancer - A Cinderella Cancer: Advances and Remaining Research Questions.
    Front Oncol. 2020;10:1749.
    Abstract     Related articles   
    
    
63. LIU X, Zhou Z, Wang Y, Zhu K, et al
    Corrigendum: Downregulation of HMGA1 Mediates Autophagy and Inhibits Migration and Invasion in Bladder Cancer via miRNA-221/TP53INP1/p-ERK Axis.
    Front Oncol. 2020;10:1735.
    Abstract     Related articles   
    
    
64. FANG M, Liu F, Huang L, Wu L, et al
    A Urine Metabonomics Study of Rat Bladder Cancer by Combining Gas Chromatography-Mass Spectrometry with Random Forest Algorithm.
    Int J Anal Chem. 2020;2020:8839215.
    Abstract     Related articles   
    
    
65. NICOLAZZO C, de Berardinis E, Gazzaniga P
    Liquid Biopsy for Predicting Bacillus Calmette-Guerin Unresponsiveness in Non-muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2020 Oct 1. pii: S2588-9311(20)30145.
    Abstract     Related articles   
    
    
66. ALVAREZ-MAESTRO M, Guerrero-Ramos F, Rodriguez-Faba O, Dominguez-Escrig JL, et al
    Current treatments for BCG failure in non-muscle invasive bladder cancer (NMIBC).
    Actas Urol Esp. 2020 Oct 1. pii: S0210-4806(20)30186.
    Abstract     Related articles   
    
    
67. NAHON I, Paterson C, Sayner A
    The Impact of Exercise and Nutrition as Part of a Person-Centered Approach to Prehabilitation in Patients with Bladder Cancer.
    Semin Oncol Nurs. 2020 Sep 30:151072. doi: 10.1016/j.soncn.2020.151072.
    Abstract     Related articles   
    
    
68. CAO Y
    [Diagnostic experience of urinary non-invasive papillary urothelial neoplasms].
    Zhonghua Bing Li Xue Za Zhi. 2020;49:1093-1096.
    Abstract     Related articles   
    
    
69. YAZAWA Y, Ikarashi N, Hoshino M, Kikkawa H, et al
    Inhibitory effect of ergosterol on bladder carcinogenesis is due to androgen signaling inhibition by brassicasterol, a metabolite of ergosterol.
    J Nat Med. 2020;74:680-688.
    Abstract     Related articles   
    
    
70. NAGUMO Y, Kawai K, Kojima T, Shiga M, et al
    Prognostic significance of non-urothelial carcinoma of bladder: analysis of nationwide hospital-based cancer registry data in Japan.
    Jpn J Clin Oncol. 2020;50:1068-1075.
    Abstract     Related articles   
    
    
71. NOUHAUD FX, Williams M, Yaxley W, Cho J, et al
    Robot-assisted orthotopic "W" ileal neobladder in male patients: step-by-step video-illustrated technique and preliminary outcomes.
    J Robot Surg. 2020;14:739-744.
    Abstract     Related articles   
    
    
72. MOSCHOVAS MC, Chade DC, Arap MA, Sarkis AS, et al
    Robotic-assisted radical cystectomy: the first multicentric Brazilian experience.
    J Robot Surg. 2020;14:703-708.
    Abstract     Related articles   
    
    
73. PAILLAS S, Then CK, Kilgas S, Ruan JL, et al
    The Histone Deacetylase Inhibitor Romidepsin Spares Normal Tissues While Acting as an Effective Radiosensitizer in Bladder Tumors in Vivo.
    Int J Radiat Oncol Biol Phys. 2020;107:212-221.
    Abstract     Related articles   
    
    
74. GHAFERI M, Asadollahzadeh MJ, Akbarzadeh A, Ebrahimi Shahmabadi H, et al
    Enhanced Efficacy of PEGylated Liposomal Cisplatin: In Vitro and In Vivo Evaluation.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   
    
    
75. REZAEE ME, Goldwag JL, Goddard B, Bihrle Iii W, et al
    Parastomal hernia development after cystectomy and ileal conduit for bladder cancer: results from the Dartmouth ileal conduit enhancement (DICE) project.
    Can J Urol. 2020;27:10369-10377.
    Abstract     Related articles   
    
    
76. LUO Y, Chen L, Zhou Q, Xiong Y, et al
    Identification of a prognostic gene signature based on an immunogenomic landscape analysis of bladder cancer.
    J Cell Mol Med. 2020 Oct 13. doi: 10.1111/jcmm.15960.
    Abstract     Related articles   
    
    
77. XU N, Lin W, Sun J, Sadahira T, et al
    Nitroxoline inhibits bladder cancer progression by reversing EMT process and enhancing anti-tumor immunity.
    J Cancer. 2020;11:6633-6641.
    Abstract     Related articles   
    
    
78. HAAS M, Huber T, Pickl C, van Rhijn BWG, et al
    The comprehensive complication index is associated with a significant increase in complication severity between 30 and 90 days after radical cystectomy for bladder cancer.
    Eur J Surg Oncol. 2020 Oct 5. pii: S0748-7983(20)30831.
    Abstract     Related articles   
    
    
79. BI J, Liu H, Dong W, Xie W, et al
    Correction to: Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence.
    Mol Cancer. 2020;19:148.
    Abstract     Related articles   
    
    
80. CARVALHO S, Abreu CM, Ferreira D, Lima L, et al
    Phenotypic Analysis of Urothelial Exfoliated Cells in Bladder Cancer via Microfluidic Immunoassays: Sialyl-Tn as a Novel Biomarker in Liquid Biopsies.
    Front Oncol. 2020;10:1774.
    Abstract     Related articles   
    
    
81. ANDERSSON N, Ohlsson J, Wahlin S, Nodin B, et al
    Lymphocyte antigen 6 superfamily member D is a marker of urothelial and squamous differentiation: implications for risk stratification of bladder cancer.
    Biomark Res. 2020;8:51.
    Abstract     Related articles   
    
    
82. TIAN Z, Meng L, Long X, Diao T, et al
    Identification and validation of an immune-related gene-based prognostic index for bladder cancer.
    Am J Transl Res. 2020;12:5188-5204.
    Abstract     Related articles   
    
    
83. ZHU H, Wang Y, Wei T, Zhao X, et al
    KAT8/MOF-Mediated Anti-Cancer Mechanism of Gemcitabine in Human Bladder Cancer Cells.
    Biomol Ther (Seoul). 2020 Oct 12. pii: biomolther.2020.
    Abstract     Related articles   
    
    
84. SUN X, Hu X, Wang X, Jiang X, et al
    MiR-381-3p/RAB2A axis activates cell proliferation and inhibits cell apoptosis in bladder cancer.
    Cell Mol Biol (Noisy-le-grand). 2020;66:117-120.
    Abstract     Related articles   
    
    
85. LU JL, Xia QD, Lu YH, Liu Z, et al
    Efficacy of intravesical therapies on the prevention of recurrence and progression of non-muscle-invasive bladder cancer: A systematic review and network meta-analysis.
    Cancer Med. 2020 Oct 11. doi: 10.1002/cam4.3513.
    Abstract     Related articles   
    
    
86. CHEN YT, Huang ZY, Tang HH, Kuo WT, et al
    Pterostilbene Sensitizes Cisplatin-Resistant Human Bladder Cancer Cells with Oncogenic HRAS.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   
    
    
87. BHARDWAJ N, Farkas AM, Gul Z, Sfakianos JP, et al
    Harnessing Natural Killer Cell Function for Genitourinary Cancers.
    Urol Clin North Am. 2020;47:433-442.
    Abstract     Related articles   
    
    
88. FARIA EF
    Editorial Comment: Does the Use of a Robot Decrease the Complication Rate Adherent to Radical Cystectomy? A Systematic Review and Meta-Analysis of Studies Comparing Open with Robotic Counterparts.
    Int Braz J Urol. 2020;46:657-658.
    Abstract     Related articles   
    
    
89. LIU Z, Sun T, Zhang Z, Bi J, et al
    An 18-gene signature based on glucose metabolism and DNA methylation improves prognostic prediction for urinary bladder cancer.
    Genomics. 2020 Oct 20. pii: S0888-7543(20)31981.
    Abstract     Related articles   
    
    
90. HUANG W, Li Y, Zhang C, Zha H, et al
    IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK/STAT signalling pathway in human bladder cancer.
    J Cell Mol Med. 2020 Oct 22. doi: 10.1111/jcmm.16003.
    Abstract     Related articles   
    
    
91. ABD-EL-RAOUF R, Ouf SA, Gabr MM, Zakaria MM, et al
    Escherichia coli foster bladder cancer cell line progression via epithelial mesenchymal transition, stemness and metabolic reprogramming.
    Sci Rep. 2020;10:18024.
    Abstract     Related articles   
    
    
92. KAMOUN W, Swindell E, Pien C, Luus L, et al
    Targeting EphA2 in Bladder Cancer Using a Novel Antibody-Directed Nanotherapeutic.
    Pharmaceutics. 2020;12.
    Abstract     Related articles   
    
    
93. LUO Q, Vogeli TA
    A Methylation-Based Reclassification of Bladder Cancer Based on Immune Cell Genes.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   
    
    
94. SHARIFUZZAMAN M, Barman SC, Zahed MA, Sharma S, et al
    An Electrodeposited MXene-Ti3C2Tx Nanosheets Functionalized by Task-Specific Ionic Liquid for Simultaneous and Multiplexed Detection of Bladder Cancer Biomarkers.
    Small. 2020 Oct 8:e2002517. doi: 10.1002/smll.202002517.
    Abstract     Related articles   
    
    
95. IZOL V, Deger M, Baltaci S, Akgul M, et al
    The Effect of Body Mass Index on Oncological and Surgical Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Multicenter Study of the Association of Urooncology, Turkey.
    Int J Clin Pract. 2020 Oct 8:e13750. doi: 10.1111/ijcp.13750.
    Abstract     Related articles   
    
    
96. XIA W, Chen C, Zhang MR, Zhu LN, et al
    LncRNA PCAT6 aggravates the progression of bladder cancer cells by targeting miR-513a-5p.
    Eur Rev Med Pharmacol Sci. 2020;24:9908-9914.
    Abstract     Related articles   
    
    
97. MORTADA WI, Awadalla A, Khater SM, Barakat NM, et al
    Preventive effect of pomegranate juice against chemically induced bladder cancer: An experimental study.
    Heliyon. 2020;6:e05192.
    Abstract     Related articles   
    
    
98. KADOURI Y, Lachkar S, Dergamoun H, El Sayegh H, et al
    Management of the Uncommon Bladder Cancers: A Single-Center Experience over 10 Years.
    Adv Urol. 2020;2020:7563703.
    Abstract     Related articles   
    
    
99. NGUYEN OTD, Sundstrom SH, Westvik GS, Rottereng AKS, et al
    Major Durable Response of Pembrolizumab in Chemotherapy Refractory Small Cell Bladder Cancer: A Case Report.
    Case Rep Oncol. 2020;13:1059-1066.
    Abstract     Related articles   
    
    
100. MOORTHY HK, Prabhu GGL, Venugopal P
     Clinical and therapeutic implications of sex steroid hormone receptor status in urothelial bladder cancer.
     Indian J Urol. 2020;36:171-178.
     Abstract     Related articles   
     
     
101. FAN Z, Huang Z, Hu C, Tong Y, et al
     Risk factors and nomogram for newly diagnosis of bone metastasis in bladder cancer: A SEER-based study.
     Medicine (Baltimore). 2020;99:e22675.
     Abstract     Related articles   
     
     
102. HALABI IE, Husseini ZE, Haibe Y, Charafeddine M, et al
     Cystectomy vs. bladder preservation after neoadjuvant chemotherapy in muscle-invasive bladder cancer: A tertiary medical center experience.
     Cancer Treat Res Commun. 2020;25:100222.
     Abstract     Related articles   
     
     
103. DEL GIUDICE F, Pecoraro M, Vargas HA, Cipollari S, et al
     Systematic Review and Meta-Analysis of Vesical Imaging-Reporting and Data System (VI-RADS) Inter-Observer Reliability: An Added Value for Muscle Invasive Bladder Cancer Detection.
     Cancers (Basel). 2020;12.
     Abstract     Related articles   
     
     
104. KRAJEWSKI W, Moschini M, Nowak L, Poletajew S, et al
     Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic Benefit.
     J Clin Med. 2020;9.
     Abstract     Related articles   
     
     
105. KACEM BEN FRADJ M, Ouanes Y, Hadj-Taeib S, Mrad Dali K, et al
     Prognostic significance of plasma folate and cobalamin concentrations in non-muscle-invasive bladder cancer: A Prospective Cohort Study.
     Cancer Invest. 2020 Oct 19:1-18. doi: 10.1080/07357907.2020.1839760.
     Abstract     Related articles   
     
     
106. ZHU H, Mo Q, Shen H, Wang S, et al
     Carbohydrates, Glycemic Index, and Glycemic Load in Relation to Bladder Cancer Risk.
     Front Oncol. 2020;10:530382.
     Abstract     Related articles   
     
     
107. MURAKAMI Y, Matsumoto K, Shimizu Y, Ikeda M, et al
     PD-L1 expression in tumor-infiltrating lymphocytes (TILs) as an independent predictor of prognosis in patients with pN0 bladder cancer undergoing radical cystectomy.
     Urol Oncol. 2020 Oct 15. pii: S1078-1439(20)30470.
     Abstract     Related articles   
     
     
108. MARANDINO L, Capozza A, Bandini M, Raggi D, et al
     [18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab.
     Urol Oncol. 2020 Oct 15. pii: S1078-1439(20)30472.
     Abstract     Related articles   
     
     
109. GULINAC M, Dikov D, Velikova T, Belovezhdov V, et al
     Increased PD-L1 expression in high-grade bladder cancer with squamous cell differentiation in Bulgarian and French patients' samples.
     Ann Diagn Pathol. 2020;49:151640.
     Abstract     Related articles   
     
     
110. MACGREGOR M, Safizadeh Shirazi H, Chan KM, Ostrikov K, et al
     Cancer cell detection device for the diagnosis of bladder cancer from urine.
     Biosens Bioelectron. 2020;171:112699.
     Abstract     Related articles   
     
     
111. TOSTIVINT V, Verhoest G, Cabarrou B, Gas J, et al
     Quality of life and functional outcomes after radical cystectomy with ileal orthotopic neobladder replacement for bladder cancer: a multicentre observational study.
     World J Urol. 2020 Oct 16. pii: 10.1007/s00345-020-03484.
     Abstract     Related articles   
     
     
112. AMBROSIO L, Argenziano M, Cucci MA, Grattarola M, et al
     Carbosilane Dendrimers Loaded with siRNA Targeting Nrf2 as a Tool to Overcome Cisplatin Chemoresistance in Bladder Cancer Cells.
     Antioxidants (Basel). 2020;9.
     Abstract     Related articles   
     
     
113. OTT PA, Hu-Lieskovan S, Chmielowski B, Govindan R, et al
     A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer.
     Cell. 2020;183:347-362.
     Abstract     Related articles   
     
     
114. AKAN S, Ediz C, Kizilkan YE, Alcin A, et al
     Covid-19 Threat in Patients with High-Risk Non-Muscle Invasive Bladder Cancer Receiving Intravesical BCG Therapy.
     Int J Clin Pract. 2020 Oct 16:e13752. doi: 10.1111/ijcp.13752.
     Abstract     Related articles   
     
     
115. YANG Z, Bai Y, Liu M, Hu X, et al
     Development and validation of a prognostic nomogram for predicting cancer-specific survival after radical cystectomy in patients with bladder cancer:A population-based study.
     Cancer Med. 2020 Oct 16. doi: 10.1002/cam4.3535.
     Abstract     Related articles   
     
     
116. CHENG C, Song D, Wu Y, Liu B, et al
     RAC3 Promotes Proliferation, Migration and Invasion via PYCR1/JAK/STAT Signaling in Bladder Cancer.
     Front Mol Biosci. 2020;7:218.
     Abstract     Related articles   
     
     
117. BI H, Shang Z, Jia C, Wu J, et al
     Predictive Values of Preoperative Prognostic Nutritional Index and Systemic Immune-Inflammation Index for Long-Term Survival in High-Risk Non-Muscle-Invasive Bladder Cancer Patients: A Single-Centre Retrospective Study.
     Cancer Manag Res. 2020;12:9471-9483.
     Abstract     Related articles   
     
     
118. YANG S, Guan H, Wang S, Wu H, et al
     Plasma Fibrinogen Predicts the Prognosis of Bladder Cancer Patients After Radical Cystectomy.
     Cancer Manag Res. 2020;12:9303-9314.
     Abstract     Related articles   
     
     
119. ZHOU Z, Liu X, Li Y, Li J, et al
     TP53INP2 Modulates Epithelial-to-Mesenchymal Transition via the GSK-3beta/beta-Catenin/Snail1 Pathway in Bladder Cancer Cells.
     Onco Targets Ther. 2020;13:9587-9597.
     Abstract     Related articles   
     
     
120. CAI Z, Li H
     Circular RNAs and Bladder Cancer.
     Onco Targets Ther. 2020;13:9573-9586.
     Abstract     Related articles   
     
     
121. YUK HD, Jeong CW, Kwak C, Kim H, et al
     Efficacy of neoadjuvant atezolizumab treatment in patients with advanced urothelial bladder cancer according to the BASQ classification: a study protocol for an open-label, two-cohort, phase II trial.
     BMJ Open. 2020;10:e035530.
     Abstract     Related articles   
     
     
122. FURRER MA, Grueter T, Bosshard P, Vartolomei MD, et al
     Routine Preoperative Bone Scintigraphy Has Limited Impact on the Management of Patients with Invasive Bladder Cancer.
     Eur Urol Focus. 2020 Oct 12. pii: S2405-4569(20)30275.
     Abstract     Related articles   
     
     
123. RODUIT A, Pouget R, Defabiani N, Troillet N, et al
     [BCGitis following intravesical administration of bacillus Calmette-Guerin].
     Rev Med Suisse. 2020;16:1920-1923.
     Abstract     Related articles   
     
     
124. PFAIL JL, Katims AB, Alerasool P, Sfakianos JP, et al
     Immunotherapy in non-muscle-invasive bladder cancer: current status and future directions.
     World J Urol. 2020 Oct 15. pii: 10.1007/s00345-020-03474.
     Abstract     Related articles   
     
     
125. LI X, Shang D, Shen H, Song J, et al
     Corrigendum to "ZSCAN16 promotes proliferation, migration and invasion of bladder cancer via regulating NF-kB, AKT, mTOR, P38 and other genes" [Biomed. Pharmacother. 126 (2020) 110066].
     Biomed Pharmacother. 2020 Oct 11:110858. doi: 10.1016/j.biopha.2020.110858.
     Abstract     Related articles   
     
     
126. HAMID ARAH, Ridwan FR, Parikesit D, Widia F, et al
     Meta-analysis of neoadjuvant chemotherapy compared to radical cystectomy alone in improving overall survival of muscle-invasive bladder cancer patients.
     BMC Urol. 2020;20:158.
     Abstract     Related articles   
     
     
127. MULLER J, Kalbermatten Magaya N, Traichel B, Taverna C, et al
     [Unusual Cause of Acute Kidney Failure in a Patient with Metastatic Bladder Carcinoma Undergoing Palliative Chemotherapy].
     Praxis (Bern 1994). 2020;109:1070-1073.
     Abstract     Related articles   
     
     
128. ECKE TH, Kiani A, Schlomm T, Friedersdorff F, et al
     Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of KRT5, KRT20, and ERBB2 in Muscle-Invasive Bladder Cancer Treated by Adjuvant Chemotherapy.
     Int J Mol Sci. 2020;21.
     Abstract     Related articles   
     
     
129. VACHER S, Suybeng V, Girard E, Masliah Planchon J, et al
     Genomic Instability Signature of Palindromic Non-Coding Somatic Mutations in Bladder Cancer.
     Cancers (Basel). 2020;12.
     Abstract     Related articles   
     
     
130. OH JY
     Autoimmune Keratitis after Atezolizumab Treatment.
     N Engl J Med. 2020;383:1468.
     Abstract     Related articles   
     
     
131. LI R, Chen H, Gong G, Wang L, et al
     Bladder Wall Segmentation in MRI Images via Deep Learning and Anatomical Constraints.
     Annu Int Conf IEEE Eng Med Biol Soc. 2020;2020:1629-1632.
     Abstract     Related articles   
     
     
132. SHIMIZU G, Amano R, Nakamura I, Wada A, et al
     Disseminated Bacillus Calmette-Guerin (BCG) infection and acute exacerbation of interstitial pneumonitis: an autopsy case report and literature review.
     BMC Infect Dis. 2020;20:708.
     Abstract     Related articles   
     
     
133. RENZI C, Lyratzopoulos G
     Comorbidity and the diagnosis of symptomatic-but-as-yet-undiagnosed cancer.
     Br J Gen Pract. 2020;70:e598-e599.
     Abstract     Related articles   
     
     
134. ASHOUR DS, Othman AA
     Parasite-bacteria interrelationship.
     Parasitol Res. 2020;119:3145-3164.
     Abstract     Related articles   
     
     
135. MAZDAK H, Gholampour M, Tolou Ghamri Z
     A Quick Review of Redox State in Cancer: Focus to Bladder.
     Gulf J Oncolog. 2020;1:59-62.
     Abstract     Related articles   
     
     
136. YU Y, Zhang W, Li A, Chen Y, et al
     Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer.
     JAMA Netw Open. 2020;3:e202149.
     Abstract     Related articles   
     
     
137. ABRANTES AM, Pires AS, Monteiro L, Teixo R, et al
     Tumour functional imaging by PET.
     Biochim Biophys Acta Mol Basis Dis. 2020;1866:165717.
     Abstract     Related articles   
     
     
138. SUNDARAM A, Gupta K, Singla S, Singh SK, et al
     Glandular-type inverted papilloma of urinary bladder - Report of a unique case with immunohistochemistry.
     Indian J Pathol Microbiol. 2020;63:96-97.
     Abstract     Related articles   
     
     
139. ROMAGNOLI D, Schiavina R, Bianchi L, Borghesi M, et al
     Is Fast Track protocol a safe tool to reduce hospitalization time after radical cystectomy with ileal urinary diversion? Initial results from a single high-volume centre.
     Arch Ital Urol Androl. 2020;91:230-236.
     Abstract     Related articles   
     
     
140. GRIFFIN MA, Culp WTN, Giuffrida MA, Ellis P, et al
     Lower urinary tract transitional cell carcinoma in cats: Clinical findings, treatments, and outcomes in 118 cases.
     J Vet Intern Med. 2020;34:274-282.
     Abstract     Related articles   
     
     
141. VIVIANI E, Bracale UM
     Re: "Ruptured Mycotic Aneurysm After Intravesical Instillation for Bladder Tumor".
     Ann Vasc Surg. 2020;65:e299.
     Abstract     Related articles   
     
     
142. ZHU X, Tong H, Gao S, Yin H, et al
     C1QTNF6 Overexpression Acts as a Predictor of Poor Prognosis in Bladder Cancer Patients.
     Biomed Res Int. 2020;2020:7139721.
     Abstract     Related articles   
     
     
143. ZHANG R, Xia J, Wang Y, Cao M, et al
     Co-Expression of Stem Cell and Epithelial Mesenchymal Transition Markers in Circulating Tumor Cells of Bladder Cancer Patients.
     Onco Targets Ther. 2020;13:10739-10748.
     Abstract     Related articles   
     
     
144. ERAY A, Guneri PY, Yilmaz GO, Karakulah G, et al
     Analysis of open chromatin regions in bladder cancer links beta-catenin mutations and Wnt signaling with neuronal subtype of bladder cancer.
     Sci Rep. 2020;10:18667.
     Abstract     Related articles   
     
     
145. WANG Q, Hu L, Ma W, Meng Z, et al
     UriBLAD - a urine-based gene expression assay for non-invasive detection of bladder cancer.
     J Mol Diagn. 2020 Oct 26. pii: S1525-1578(20)30519.
     Abstract     Related articles   
     
     
146. LIU J, Wu P, Lai S, Song X, et al
     Preoperative Monocyte-to-lymphocyte Ratio Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
     Clin Genitourin Cancer. 2020 Sep 18. pii: S1558-7673(20)30220.
     Abstract     Related articles   
     
     
147. HUANG X, Yan Y, Wei R, Liu H, et al
     Centrosome Protein 78 Is Overexpressed in Muscle-Invasive Bladder Cancer and Is Associated with Tumor Molecular Subtypes and Mutation Signatures.
     Med Sci Monit. 2020;26:e925197.
     Abstract     Related articles   
     
     
148. HOWARD JM, Margulis V, Woldu SL
     Clinical outcomes of a cohort of patients with bulky, clinically node-positive bladder cancer undergoing radical cystectomy in the contemporary era.
     Can Urol Assoc J. 2020 Oct 27. pii: cuaj.6966. doi: 10.5489/cuaj.6966.
     Abstract     Related articles   
     
     
149. JENSEN BT, Lauridsen SV, Jensen JB
     Optimal Delivery of Follow-Up Care After Radical Cystectomy for Bladder Cancer.
     Res Rep Urol. 2020;12:471-486.
     Abstract     Related articles   
     
     
150. HOCKMAN L, Bailey J, Sanders J, Muzzey C, et al
     A Qualitative Assessment of Patient Satisfaction with Radical Cystectomy for Bladder Cancer at a Single Institution: How Can We Improve?
     Res Rep Urol. 2020;12:447-453.
     Abstract     Related articles   
     
     
151. LONG Q, An X, Chen M, Wang N, et al
     PUF60/AURKA Axis Contributes to Tumor Progression and Malignant Phenotypes in Bladder Cancer.
     Front Oncol. 2020;10:568015.
     Abstract     Related articles   
     
     
152. TANG C, Ma J, Liu X, Liu Z, et al
     Identification of Four Immune Subtypes in Bladder Cancer Based on Immune Gene Sets.
     Front Oncol. 2020;10:544610.
     Abstract     Related articles   
     
     
153. ZHANG R, Wang Z, You W, Zhou F, et al
     Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K/AKT/mTOR signaling pathways and EMT.
     Cancer Cell Int. 2020;20:520.
     Abstract     Related articles   
     
     
154. LI D, Li A, Yang Y, Feng D, et al
     Clinical Characteristics and Prognosis of Rare Histological Variants of Bladder Cancer: A Single-Center Retrospective Study from China.
     Cancer Manag Res. 2020;12:9635-9641.
     Abstract     Related articles   
     
     
155. 
     Erratum: GRHL2 Acts as an Anti-Oncogene in Bladder Cancer by Regulating ZEB1 in Epithelial-Mesenchymal Transition (EMT) Process [Erratum].
     Onco Targets Ther. 2020;13:10759.
     Abstract     Related articles   
     
     
156. ZHANG L, Liang J, Liu X, Wu J, et al
     Aloperine Exerts Antitumor Effects on Bladder Cancer in vitro.
     Onco Targets Ther. 2020;13:10351-10360.
     Abstract     Related articles   
     
     
157. TANG C, Ma J, Liu X, Liu Z, et al
     Development and validation of a novel stem cell subtype for bladder cancer based on stem genomic profiling.
     Stem Cell Res Ther. 2020;11:457.
     Abstract     Related articles   
     
     
158. CAVALLARI I, Grassi A, Del Bianco P, Aceti A, et al
     Prognostic Stratification of Bladder Cancer Patients with a MicroRNA-based Approach.
     Cancers (Basel). 2020;12.
     Abstract     Related articles   
     
     
159. OLAH C, Tschirdewahn S, Hoffmann MJ, Krafft U, et al
     Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients.
     Diagnostics (Basel). 2020;10.
     Abstract     Related articles   
     
     
160. LIU J, Zhang Y, Yu C, Zhang P, et al
     Bergenin inhibits bladder cancer progression via activating the PPARgamma/PTEN/Akt signal pathway.
     Drug Dev Res. 2020 Oct 28. doi: 10.1002/ddr.21751.
     Abstract     Related articles   
     
     
161. WANG P, Zang S, Li G, Qu W, et al
     The role of surgery on the primary tumor site in bladder cancer with distant metastasis: significance of histology type and metastatic pattern.
     Cancer Med. 2020 Oct 27. doi: 10.1002/cam4.3560.
     Abstract     Related articles   
     
     
162. OTO J, Plana E, Fernandez-Pardo A, Cana F, et al
     Identification of miR-29c-3p as a Robust Normalizer for Urine microRNA Studies in Bladder Cancer.
     Biomedicines. 2020;8.
     Abstract     Related articles   
     
     
163. SHEN D, Xu J, Cao X, Cao X, et al
     Long noncoding RNA MAGI2-AS3 inhibits bladder cancer progression through MAGI2/PTEN/epithelial-mesenchymal transition (EMT) axis.
     Cancer Biomark. 2020 Oct 13. pii: CBM201421. doi: 10.3233/CBM-201421.
     Abstract     Related articles   
     
     
164. MASSAFRA M, Passalacqua MI, Lupo G, Altavilla G, et al
     Capillary leak syndrome induced by neoadjuvant cisplatin and gemcitabine in a patient with bladder cancer.
     Urol Case Rep. 2020 Oct 21:101461. doi: 10.1016/j.eucr.2020.101461.
     Abstract     Related articles   
     
     
165. MBANEFO EC, Agbo CT, Zhao Y, Lamanna OK, et al
     IPSE, an abundant egg-secreted protein of the carcinogenic helminth Schistosoma haematobium, promotes proliferation of bladder cancer cells and angiogenesis.
     Infect Agent Cancer. 2020;15:63.
     Abstract     Related articles   
     
     
166. CORAGGIO G, Husheng S, Loganadane G, Ghith S, et al
     Hemostatic radiotherapy for bladder cancer-related hematuria in patients unfit for surgery: is there any impact of fractionation schedule?
     J BUON. 2020;25:2092-2096.
     Abstract     Related articles   
     
     
167. WAHBY S, Jarczyk J, Fierek A, Heinkele J, et al
     POFUT1 mRNA expression as an independent prognostic parameter in muscle-invasive bladder cancer.
     Transl Oncol. 2020;14:100900.
     Abstract     Related articles   
     
     
168. WANG Y, Chen J, Wang X, Wang K, et al
     miR-140-3p inhibits bladder cancer cell proliferation and invasion by targeting FOXQ1.
     Aging (Albany NY). 2020;12.
     Abstract     Related articles   
     
     
169. SAHATSAPAN N, Ngawhirunpat T, Rojanarata T, Opanasopit P, et al
     Catechol-Functionalized Alginate Nanoparticles as Mucoadhesive Carriers for Intravesical Chemotherapy.
     AAPS PharmSciTech. 2020;21:212.
     Abstract     Related articles   
     
     
170. LUZZAGO S, Palumbo C, Rosiello G, Pecoraro A, et al
     The Effect of Systemic Chemotherapy on Survival in Patients With Localized, Regional, or Metastatic Adenocarcinoma of the Urinary Bladder.
     Am J Clin Oncol. 2020;43:567-574.
     Abstract     Related articles   
     
     
171. TANG Y, Chen J, Dai M, Li L, et al
     Imaging features of inflammatory myofibroblastic tumour in the urinary bladder.
     Br J Hosp Med (Lond). 2020;81:1-2.
     Abstract     Related articles   
     
     
172. JANARDANAN S, Rifat M, Patil K
     Zero clamping technique during radical cystectomy.
     Ann R Coll Surg Engl. 2020;102:545-546.
     Abstract     Related articles   
     
     
173. NGUYEN JK, Przybycin CG, McKenney JK, Magi-Galluzzi C, et al
     Immunohistochemical staining patterns of Ki-67 and p53 in florid reactive urothelial atypia and urothelial carcinoma in situ demonstrate significant overlap.
     Hum Pathol. 2020;98:81-88.
     Abstract     Related articles   
     
     
174. AKGUL M, MacLennan GT, Cheng L
     The applicability and utility of immunohistochemical biomarkers in bladder pathology.
     Hum Pathol. 2020;98:32-55.
     Abstract     Related articles   
     
     
175. PALUMBO C, Knipper S, Pecoraro A, Rosiello G, et al
     Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy.
     Surg Oncol. 2020;32:8-13.
     Abstract     Related articles   
     
     
176. AKAN S, Ediz C, Sahin A, Tavukcu HH, et al
     Can the systemic immune inflammation index be a predictor of bcg response in patients with high-risk non-muscle invasive bladder cancer?
     Int J Clin Pract. 2020 Nov 5. doi: 10.1111/ijcp.13813.
     Abstract     Related articles   
     
     
177. YILMAZ M, Sahin Y, Ates HA, Hacibey I, et al
     De Ritis ratio: how effectively we can use in bladder cancer management?
     Biomark Med. 2020 Nov 5. doi: 10.2217/bmm-2020-0212.
     Abstract     Related articles   
     
     
178. NING XH, Qi YY, Wang FX, Li SC, et al
     A Three Protein-Coding Gene Prognostic Model Predicts Overall Survival in Bladder Cancer Patients.
     Biomed Res Int. 2020;2020:7272960.
     Abstract     Related articles   
     
     
179. WANG H, Niu X, Mao F, Liu X, et al
     Hsa_circRNA_100146 Acts as a Sponge of miR-149-5p in Promoting Bladder Cancer Progression via Regulating RNF2.
     Onco Targets Ther. 2020;13:11007-11017.
     Abstract     Related articles   
     
     
180. YANG J, Chen J, Wu S, Fei X, et al
     Microarray Expression Profiles and Bioinformatics Analyses Reveal Aberrant Circular RNAs Expression in Bladder Cancer.
     Onco Targets Ther. 2020;13:10889-10899.
     Abstract     Related articles   
     
     
181. RIVANO M, Cancanelli L, Spazio LD, Chiumente M, et al
     Restricted mean survival time as outcome measure in advanced urothelial bladder cancer: analysis of 4 clinical studies.
     Immunotherapy. 2020 Nov 5. doi: 10.2217/imt-2020-0160.
     Abstract     Related articles   
     
     
182. IKEDA A, Nosato H, Kochi Y, Negoro H, et al
     Cystoscopic imaging for bladder cancer detection based on stepwise organic transfer learning with a pre-trained convolutional neural network.
     J Endourol. 2020 Nov 4. doi: 10.1089/end.2020.0919.
     Abstract     Related articles   
     
     
183. LEI T, Gong B, Meng Q, Zhang M, et al
     Transthyretin in bladder cancer.
     J Biol Regul Homeost Agents. 2020;34.
     Abstract     Related articles   
     
     
184. SUN YU, Nishino H, Zhao M, Miyake K, et al
     A Non-invasive Imageable GFP-expressing Mouse Model of Orthotopic Human Bladder Cancer.
     In Vivo. 2020;34:3225-3231.
     Abstract     Related articles   
     
     
185. PETRELLA G, Ciufolini G, Vago R, Cicero DO, et al
     The Interplay between Oxidative Phosphorylation and Glycolysis as a Potential Marker of Bladder Cancer Progression.
     Int J Mol Sci. 2020;21.
     Abstract     Related articles   
     
     
186. ZHU J, Zhu Z, Cai P, Gu Z, et al
     Bladder cancer-associated transcript 2 contributes to nephroblastoma progression.
     J Gene Med. 2020 Nov 3:e3292. doi: 10.1002/jgm.3292.
     Abstract     Related articles   
     
     
187. ZHANG D, Du D, Yi S, Li X, et al
     LncRNA PCAT6: A potential biomarker for diagnosis and prognosis of bladder cancer.
     Ann Diagn Pathol. 2020;49:151642.
     Abstract     Related articles   
     
     
188. ROUANNE M, Radulescu C, Adam J, Allory Y, et al
     PD-L1 testing in urothelial bladder cancer: essentials of clinical practice.
     World J Urol. 2020 Nov 3. pii: 10.1007/s00345-020-03498.
     Abstract     Related articles   
     
     
189. GABER DA, Wassef RM, El-Ayat WM, El-Moazen MI, et al
     Role of a schistosoma haematobium specific microRNA as a predictive and prognostic tool for bilharzial bladder cancer in Egypt.
     Sci Rep. 2020;10:18844.
     Abstract     Related articles   
     
     
190. KIM J, Jin P, Yang W, Kim WJ, et al
     Proteomic profiling of bladder cancer for precision medicine in the clinical setting: A review for the busy urologist.
     Investig Clin Urol. 2020;61:539-554.
     Abstract     Related articles   
     
     
191. CHIANCONE F, Fabiano M, Fedelini M, Meccariello C, et al
     Outcomes and complications of Hyperthermic IntraVesical Chemotherapy using mitomycin C or epirubicin for patients with non-muscle invasive bladder cancer after bacillus Calmette-Guerin treatment failure.
     Cent European J Urol. 2020;73:287-294.
     Abstract     Related articles   
     
     
192. KOURBANHOUSSEN K, McMartin C, Lodde M, Zlotta A, et al
     Switching Cancers: A Systematic Review Assessing the Role of Androgen Suppressive Therapy in Bladder Cancer.
     Eur Urol Focus. 2020 Oct 29. pii: S2405-4569(20)30286.
     Abstract     Related articles   
     
     
193. SAVCHUK R, Kostyev F, Dekhtiar Y
     URODYNAMIC PATTERNS OF ARTIFICIAL BLADDER.
     Georgian Med News. 2020;:7-10.
     Abstract     Related articles   
     
     
194. SETTI BOUBAKER N, Gurtner A, Trabelsi N, Manni I, et al
     Uncovering the expression patterns and the clinical significance of miR-182, miR-205, miR-27a and miR-369 in patients with urinary bladder cancer.
     Mol Biol Rep. 2020 Oct 31. pii: 10.1007/s11033-020-05932.
     Abstract     Related articles   
     
     
195. LIU Y, Huang W, Cai Z
     Synthesizing AND gate minigene circuits based on CRISPReader for identification of bladder cancer cells.
     Nat Commun. 2020;11:5486.
     Abstract     Related articles   
     
     
196. DINH TT, Mitin T, Bagshaw HP, Hoffman KE, et al
     Executive Summary of the American Radium Society Appropriate Use Criteria for Radiation Treatment of Node-Negative Muscle Invasive Bladder Cancer.
     Int J Radiat Oncol Biol Phys. 2020 Oct 27. pii: S0360-3016(20)34448.
     Abstract     Related articles   
     
     
197. RINK M, Riethdorf S, Yu H, Kolker M, et al
     The Impact of Circulating Tumor Cells on Venous Thromboembolism and Cardiovascular Events in Bladder Cancer Patients Treated with Radical Cystectomy.
     J Clin Med. 2020;9.
     Abstract     Related articles   
     
     
198. BRAVETTI C, Le Garff-Tavernier M, De Septenville A, Maloum K, et al
     Watch out for a second train.
     Ann Biol Clin (Paris). 2020;78:527-536.
     Abstract     Related articles   
     
     
199. LI R, Du Y, Chen Z, Xu D, et al
     Macroscopic somatic clonal expansion in morphologically normal human urothelium.
     Science. 2020;370:82-89.
     Abstract     Related articles   
     
     
200. LAWSON ARJ, Abascal F, Coorens THH, Hooks Y, et al
     Extensive heterogeneity in somatic mutation and selection in the human bladder.
     Science. 2020;370:75-82.
     Abstract     Related articles   
     
     
201. JUSZCZAK K, Gastecka A, Adamowicz J, Adamczyk P, et al
     Health-related quality of life is not related to laparoscopic or robotic technique in radical cystectomy.
     Adv Clin Exp Med. 2020;29:857-863.
     Abstract     Related articles   
     
     
202. EL KAWAK M, Dhaini HR, Jabbour ME, Moussa MA, et al
     Slow N-acetylation as a possible contributor to bladder carcinogenesis.
     Mol Carcinog. 2020;59:1017-1027.
     Abstract     Related articles   
     
     
203. ZHU J, Zheng G, Xu H, Jin X, et al
     Expression and prognostic significance of pyruvate dehydrogenase kinase 1 in bladder urothelial carcinoma.
     Virchows Arch. 2020;477:637-649.
     Abstract     Related articles   
     
     
204. ZHOU Y, Abel GA, Hamilton W, Singh H, et al
     Imaging activity possibly signalling missed diagnostic opportunities in bladder and kidney cancer: A longitudinal data-linkage study using primary care electronic health records.
     Cancer Epidemiol. 2020;66:101703.
     Abstract     Related articles   
     
     
205. ANAND K, Ensor J, Pingali SR, Hwu P, et al
     T-cell lymphoma secondary to checkpoint inhibitor therapy.
     J Immunother Cancer. 2020;8.
     Abstract     Related articles   
     
     
206. GHOSH M, Gauger M, Marcu A, Nelde A, et al
     Guidance Document: Validation of a High-Performance Liquid Chromatography-Tandem Mass Spectrometry Immunopeptidomics Assay for the Identification of HLA Class I Ligands Suitable for Pharmaceutical Therapies.
     Mol Cell Proteomics. 2020;19:432-443.
     Abstract     Related articles   
     
     
207. SOLOWAY M, Matulay JT, Kamat AM
     A Case for Risk-adapted Management of Low-grade Bladder Tumors.
     Eur Urol Oncol. 2020;3:128-129.
     Abstract     Related articles   
     
     
208. ZHAO M, Sun Y, Gao Z, Cui H, et al
     Gigantol Attenuates the Metastasis of Human Bladder Cancer Cells, Possibly Through Wnt/EMT Signaling.
     Onco Targets Ther. 2020;13:11337-11346.
     Abstract     Related articles   
     
     
209. BI H, Shang Z, Jia C, Wu J, et al
     LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis.
     Onco Targets Ther. 2020;13:11277-11288.
     Abstract     Related articles   
     
     
210. HE H, Xie H, Chen Y, Li C, et al
     Global, regional, and national burdens of bladder cancer in 2017: estimates from the 2017 global burden of disease study.
     BMC Public Health. 2020;20:1693.
     Abstract     Related articles   
     
     
211. HOWARD JM, Woldu S, Daneshmand S, Lotan Y, et al
     Enhanced endoscopy with IMAGE1 S CHROMA improves detection of non-muscle invasive bladder cancer during transurethral resection.
     J Endourol. 2020 Nov 11. doi: 10.1089/end.2020.0821.
     Abstract     Related articles   
     
     
212. WANG L, Li H, Qiao Q, Ge Y, et al
     Circular RNA circSEMA5A promotes bladder cancer progression by upregulating ENO1 and SEMA5A expression.
     Aging (Albany NY). 2020;12.
     Abstract     Related articles   
     
     
213. LAI C, Wu Z, Shi J, Li K, et al
     Autophagy-related long noncoding RNAs can predict prognosis in patients with bladder cancer.
     Aging (Albany NY). 2020;12.
     Abstract     Related articles   
     
     
214. IINUMA K, Yuhara K, Kotaka H, Ozawa K, et al
     Preoperative predictive factors of carcinoma in situ in the normal-appearing mucosa in patients who underwent an initial transurethral resection for non-muscle-invasive bladder cancer under white light cystoscopy.
     Cancer Rep (Hoboken). 2020 Nov 11:e1321. doi: 10.1002/cnr2.1321.
     Abstract     Related articles   
     
     
215. SHAHID M, Yeon A, Kim J
     Metabolomic and lipidomic approaches to identify biomarkers for bladder cancer and interstitial cystitis (Review).
     Mol Med Rep. 2020;22:5003-5011.
     Abstract     Related articles   
     
     
216. RODRIGUES D, Teixeira L, Garcia S, Pinto MG, et al
     Outcome of radiotherapy for invasive bladder cancer in older patients - not candidates for or decline cystectomy.
     Cancer Radiother. 2020 Nov 7. pii: S1278-3218(20)30296.
     Abstract     Related articles   
     
     
217. MARANDINO L, Capozza A, Bandini M, Raggi D, et al
     Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy.
     Eur Urol Focus. 2020 Nov 7. pii: S2405-4569(20)30287.
     Abstract     Related articles   
     
     
218. LI F, Guo H, Liu B, Liu N, et al
     Explore prognostic biomarker of bladder cancer based on competing endogenous network.
     Biosci Rep. 2020 Nov 10. pii: 226921. doi: 10.1042/BSR20202463.
     Abstract     Related articles   
     
     
219. ALJABERY F, Jancke G, Skoglund P, Hallbook O, et al
     Stapled versus robot-sewn ileo-ileal anastomosis during robot-assisted radical cystectomy: a review of outcomes in urinary bladder cancer patients.
     Scand J Urol. 2020 Nov 10:1-5. doi: 10.1080/21681805.2020.1843534.
     Abstract     Related articles   
     
     
220. ZAREINEJAD M, Faghih Z, Ariafar A, Safaei A, et al
     Establishment of a bladder cancer cell line expressing both mesenchymal and epithelial lineage-associated markers.
     Hum Cell. 2020 Nov 9. pii: 10.1007/s13577-020-00456.
     Abstract     Related articles   
     
     
221. DATE AA, Kates M, Yoshida T, Babu T, et al
     Preclinical evaluation of a hypotonic docetaxel nanosuspension formulation for intravesical treatment of non-muscle-invasive bladder cancer.
     Drug Deliv Transl Res. 2020 Nov 8. pii: 10.1007/s13346-020-00870.
     Abstract     Related articles   
     
     
222. ZHENG Y, Pei Y, Yang L, Zeng Z, et al
     Upregulated GRB7 promotes proliferation and tumorigenesis of Bladder Cancer via Phospho-AKT Pathway.
     Int J Biol Sci. 2020;16:3221-3230.
     Abstract     Related articles   
     
     
223. HU D, Xu X, Zhao Z, Li C, et al
     Detecting urine metabolites of bladder cancer by surface-enhanced Raman spectroscopy.
     Spectrochim Acta A Mol Biomol Spectrosc. 2020;247:119108.
     Abstract     Related articles   
     
     
224. TELLINI R, Mari A, Muto G, Cacciamani GE, et al
     Impact of Smoking Habit on Perioperative Morbidity in Patients Treated with Radical Cystectomy for Urothelial Bladder Cancer: A Systematic Review and Meta-analysis.
     Eur Urol Oncol. 2020 Nov 4. pii: S2588-9311(20)30171.
     Abstract     Related articles   
     
     
225. ZHANG S, Shi Z, Pang K, He H, et al
     MAP30 Inhibits Bladder Cancer Cell Migration and Invasion In Vitro Through Suppressing Akt Pathway and the Epithelial/Mesenchymal Transition Process.
     DNA Cell Biol. 2020;39:1948-1960.
     Abstract     Related articles   
     
     
226. DONG ZC, Zhang D, Wang SB, Lin ZQ, et al
     Target inhibition on GSK-3beta by miR-9 to modulate proliferation and apoptosis of bladder cancer cells.
     Eur Rev Med Pharmacol Sci. 2020;24:10301.
     Abstract     Related articles   
     
     
227. DING H, Fan N, Ning Z, Ma D, et al
     Trimodal Therapy vs. Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Meta-Analysis.
     Front Oncol. 2020;10:564779.
     Abstract     Related articles   
     
     
228. ALFANO M, Salonia A, Necchi A
     Re: Madhuri Koti, Molly A. Ingersoll, Shilpa Gupta, et al. Sex Differences in Bladder Cancer Immunobiology and Outcomes: A Collaborative Review with Implications for Treatment. Eur Urol Oncol 2020;3:622-30.
     Eur Urol Oncol. 2020 Nov 3. pii: S2588-9311(20)30172.
     Abstract     Related articles   
     
     
229. BALLAS L, Singh P, Lerner SP
     Targeting barriers to wider use of trimodality therapy in localized muscle invasive bladder cancer.
     Urol Oncol. 2020 Nov 2. pii: S1078-1439(20)30478.
     Abstract     Related articles   
     
     
230. LOPEZ-BELTRAN A, Cheng L
     Stage T1 bladder cancer: diagnostic criteria and pitfalls.
     Pathology. 2020 Nov 3. pii: S0031-3025(20)30943.
     Abstract     Related articles   
     
     
231. 
     [Consensus on immunohistochemical detection of PD-L1 (SP263) in bladder invasive urothelial carcinoma].
     Zhonghua Bing Li Xue Za Zhi. 2020;49:1102-1107.
     Abstract     Related articles   
     
     
232. YU J, Lim B, Lee Y, Park JY, et al
     Risk factors and outcomes of myocardial injury after non-cardiac surgery in high-risk patients who underwent radical cystectomy.
     Medicine (Baltimore). 2020;99:e22893.
     Abstract     Related articles   
     
     
233. PIVOVARCIKOVA K, Svajdler M, Hes O
     Immunohistochemistry in hollow urinary tract.
     Cesk Patol. 2020;56:140-152.
     Abstract     Related articles   
     
     
234. GROSS AJ, Netsch C, Stolzenburg JU, Becker B, et al
     [Upper urinary tract urothelial cell carcinoma].
     Urologe A. 2020;59:1265-1274.
     Abstract     Related articles   
     
     
235. GRULLICH C, Kubler H
     [Urothelial carcinoma: immuno-oncology on all fronts].
     Urologe A. 2020;59:783.
     Abstract     Related articles   
     
     
236. BARIZZI J, Freguia S, Sarro R, Venzi G, et al
     Prostatic Ductal Adenocarcinoma with Papillary Features in a Bladder Washing: A Possible Pitfall in Urinary Cytology - Report of One Case.
     Acta Cytol. 2020;64:607-611.
     Abstract     Related articles   
     
     
237. DE FALCO F, Urraro C, Cutarelli A, Roperto S, et al
     Bovine papillomavirus E5 oncoprotein upregulates parkin-dependent mitophagy in urothelial cells of cattle with spontaneous papillomavirus infection: A mechanistic study.
     Comp Immunol Microbiol Infect Dis. 2020;70:101463.
     Abstract     Related articles   
     
     
238. ROUBAL K, Myint ZW, Kolesar JM
     Erdafitinib: A novel therapy for FGFR-mutated urothelial cancer.
     Am J Health Syst Pharm. 2020;77:346-351.
     Abstract     Related articles   
     
     
239. DELANGHE SE, Speeckaert MM, Delanghe JR
     How to assess renal function in patients with a neobladder.
     Clin Chim Acta. 2020;504:154.
     Abstract     Related articles   
     
     
240. ELMETWALI T, Salman A, Wei W, Hussain SA, et al
     CD40L membrane retention enhances the immunostimulatory effects of CD40 ligation.
     Sci Rep. 2020;10:342.
     Abstract     Related articles   
     
     
241. YASUTOMI E, Yano Y, Kodama Y
     Urinary bladder metastasis of hepatocellular carcinoma incidentally revealed by hematuria.
     Dig Liver Dis. 2020;52:115.
     Abstract     Related articles   
     
     
242. D'ANDREA D, Abufaraj M, Soria F, Gust K, et al
     Association of super-extended lymphadenectomy at radical cystectomy with perioperative complications and re-hospitalization.
     World J Urol. 2020;38:121-128.
     Abstract     Related articles   
     
     
243. BABOUDJIAN M, Al-Balushi K, Michel F, Lannes F, et al
     Diagnostic ureteroscopy prior to nephroureterectomy for urothelial carcinoma is associated with a high risk of bladder recurrence despite technical precautions to avoid tumor spillage.
     World J Urol. 2020;38:159-165.
     Abstract     Related articles   
     
     
244. WANG X, Chen F, Gou S
     Anti-tumor effects and cell motility inhibition of the DN604-gemcitabine combined treatment in human bladder cancer models.
     Bioorg Med Chem. 2020 Nov 7:115858. doi: 10.1016/j.bmc.2020.115858.
     Abstract     Related articles   
     
     
245. CAI PY, Khan AI, Scherr DS, Shoag JE, et al
     Robotic Radical Cystectomy in the Contemporary Management of Bladder Cancer.
     Urol Clin North Am. 2021;48:45-50.
     Abstract     Related articles   
     
     
246. SANTHA S, Ling X, Aljahdali IAM, Rasam SS, et al
     Mutant Kras as a Biomarker Plays a Favorable Role in FL118-Induced Apoptosis, Reactive Oxygen Species (ROS) Production and Modulation of Survivin, Mcl-1 and XIAP in Human Bladder Cancer.
     Cancers (Basel). 2020;12.
     Abstract     Related articles   
     
     
247. PENG X, Wang J, Li D, Chen X, et al
     Identification of grade-related genes and construction of a robust genomic-clinicopathologic nomogram for predicting recurrence of bladder cancer.
     Medicine (Baltimore). 2020;99:e23179.
     Abstract     Related articles   
     
     
248. MEI Y, Zheng J, Xiang P, Liu C, et al
     Prognostic value of the miR-200 family in bladder cancer: A systematic review and meta-analysis.
     Medicine (Baltimore). 2020;99:e22891.
     Abstract     Related articles   
     
     
249. MERRILL NM, Vandecan NM, Day KC, Palmbos PL, et al
     MEK is a promising target in the basal subtype of bladder cancer.
     Oncotarget. 2020;11:3921-3932.
     Abstract     Related articles   
     
     
250. DEL GIUDICE F, Campa R, Bicchetti M, De Berardinis E, et al
     Vesical Imaging-Reporting and Data System (VI-RADS) incorporated into bladder cancer clinical practice: what's the perspectives beyond diagnostic accuracy?
     Transl Androl Urol. 2020;9:2320-2322.
     Abstract     Related articles   
     
     
251. KRIEGMAIR MC, Bolenz C
     Re: "Multiparametric cystoscopy: opportunities to enhance bladder cancer detection".
     Transl Androl Urol. 2020;9:2318-2319.
     Abstract     Related articles   
     
     
252. PARIZI PK, Yarahmadi F, Tabar HM, Hosseini Z, et al
     MicroRNAs and target molecules in bladder cancer.
     Med Oncol. 2020;37:118.
     Abstract     Related articles   
     
     
253. NOUHAUD FX, Chakroun M, Lenormand C, Ouzaid I, et al
     Comparison of the prognosis of primary vs. progressive muscle invasive bladder cancer after radical cystectomy: Results from a large multicenter study.
     Urol Oncol. 2020 Nov 16. pii: S1078-1439(20)30424.
     Abstract     Related articles   
     
     
254. JORDAHL KM, Phipps AI, Randolph TW, Tinker LF, et al
     Mediation by differential DNA methylation of known associations between single nucleotide polymorphisms and bladder cancer risk.
     BMC Med Genet. 2020;21:228.
     Abstract     Related articles   
     
     
255. YING H, Fengying S, Feng H, Yanhong W, et al
     Diagnostic value of quantification of circulating free DNA for gall bladder cancer using a chemiluminescence DNA biosensor system based on DNA G-quadruplex/ hemin enzyme.
     Transl Oncol. 2020;14:100928.
     Abstract     Related articles   
     
     
256. DELLI PIZZI A, Mastrodicasa D, Marchioni M, Primiceri G, et al
     Bladder cancer: do we need contrast injection for MRI assessment of muscle invasion? A prospective multi-reader VI-RADS approach.
     Eur Radiol. 2020 Nov 19. pii: 10.1007/s00330-020-07473.
     Abstract     Related articles   
     
     
257. POUDEL R, Shah A
     Incidence of Incidental Gall Bladder Cancer and Role of Routine Histopathological Examination in Cholecystectomies Specimens for Benign Disease.
     J Nepal Health Res Counc. 2020;18:547-550.
     Abstract     Related articles   
     
     
258. TAYLOR J, Matulewicz RS
     Multiparametric cystoscopy: opportunities to enhance bladder cancer detection.
     Transl Androl Urol. 2020;9:2302-2304.
     Abstract     Related articles   
     
     
259. HUANG H, Fan X, Zhang X, Xie Y, et al
     LncRNA CARLo-7 facilitates proliferation, migration, invasion, and EMT of bladder cancer cells by regulating Wnt/beta-catenin and JAK2/STAT3 signaling pathways.
     Transl Androl Urol. 2020;9:2251-2261.
     Abstract     Related articles   
     
     
260. BOWDEN M, Nadal R, Zhou CW, Werner L, et al
     Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancer.
     Sci Rep. 2020;10:20135.
     Abstract     Related articles   
     
     
261. RAMMANT E, Deforche B, Van Hecke A, Verhaeghe S, et al
     Development of a pre- and postoperative physical activity promotion program integrated in the electronic health system of patients with bladder cancer (The POPEYE study): An intervention mapping approach.
     Eur J Cancer Care (Engl). 2020 Nov 17:e13363. doi: 10.1111/ecc.13363.
     Abstract     Related articles   
     
     
262. NADLER N, Kvich L, Bjarnsholt T, Bjerggaard Jensen J, et al
     The discovery of bacterial biofilm in patients with muscle invasive bladder cancer.
     APMIS. 2020 Nov 18. doi: 10.1111/apm.13097.
     Abstract     Related articles   
     
     
263. YAN Y, Zhang H, Jiang C, Ma X, et al
     Human papillomavirus prevalence and integration status in tissue samples of bladder cancer in Chinese population.
     J Infect Dis. 2020 Nov 18. pii: 5986718. doi: 10.1093.
     Abstract     Related articles   
     
     
264. ZHAO X, Tang Y, Ren H, Lei Y, et al
     Identification of Prognosis-Related Genes in Bladder Cancer Microenvironment across TCGA Database.
     Biomed Res Int. 2020;2020:9143695.
     Abstract     Related articles   
     
     
265. YANG J, Jian Z, Shen P, Bai Y, et al
     Associations between Interleukin-32 Gene Polymorphisms rs12934561 and rs28372698 and Susceptibilities to Bladder Cancer and the Prognosis in Chinese Han Population.
     Dis Markers. 2020;2020:8860445.
     Abstract     Related articles   
     
     
266. CAO R, Ma B, Wang G, Xiong Y, et al
     An Epithelial-Mesenchymal Transition (EMT) Preoperative Nomogram for Prediction of Lymph Node Metastasis in Bladder Cancer (BLCA).
     Dis Markers. 2020;2020:8833972.
     Abstract     Related articles   
     
     
267. LIU J, Yu X, Liu B, Yu H, et al
     Phosphorylated MAPK14 Promotes the Proliferation and Migration of Bladder Cancer Cells by Maintaining RUNX2 Protein Abundance.
     Cancer Manag Res. 2020;12:11371-11382.
     Abstract     Related articles   
     
     
268. LAI CH, Xu K, Zhou J, Wang M, et al
     DEPDC1B is a tumor promotor in development of bladder cancer through targeting SHC1.
     Cell Death Dis. 2020;11:986.
     Abstract     Related articles   
     
     
269. PAPADAKI V, Asada K, Watson JK, Tamura T, et al
     Two Secreted Proteoglycans, Activators of Urothelial Cell-Cell Adhesion, Negatively Contribute to Bladder Cancer Initiation and Progression.
     Cancers (Basel). 2020;12.
     Abstract     Related articles   
     
     
270. LENIS AT, Lec PM, Chamie K, Mshs MD, et al
     Bladder Cancer: A Review.
     JAMA. 2020;324:1980-1991.
     Abstract     Related articles   
     
     
271. LENIS AT, Lec PM, Chamie K
     Bladder Cancer.
     JAMA. 2020;324:2006.
     Abstract     Related articles   
     
     
272. ANDOLFI C, Bloodworth JC, Papachristos A, Sweis RF, et al
     The Urinary Microbiome and Bladder Cancer: Susceptibility and Immune Responsiveness.
     Bladder Cancer. 2020;6:225-235.
     Abstract     Related articles   
     
     
273. TAO L, Pan X, Zhang L, Wang J, et al
     Marital Status and Prognostic Nomogram for Bladder Cancer With Distant Metastasis: A SEER-Based Study.
     Front Oncol. 2020;10:586458.
     Abstract     Related articles   
     
     
274. ZUCALI PA, Cordua N, D'Antonio F, Borea F, et al
     Current Perspectives on Immunotherapy in the Peri-Operative Setting of Muscle-Infiltrating Bladder Cancer.
     Front Oncol. 2020;10:568279.
     Abstract     Related articles   
     
     
275. PENG YL, Wu ZS, Lu HM, Wei WS, et al
     Prognostic significance of tumor-infiltrating immune cells in muscle-invasive bladder cancer.
     Am J Transl Res. 2020;12:6524-6536.
     Abstract     Related articles   
     
     
276. YAN L, Li Q, Sun K, Jiang F, et al
     MiR-4644 is upregulated in plasma exosomes of bladder cancer patients and promotes bladder cancer progression by targeting UBIAD1.
     Am J Transl Res. 2020;12:6277-6289.
     Abstract     Related articles   
     
     
277. DOSHI GK, Bhanegaonkar A, Kearney M, Bharmal M, et al
     Treatment Sequencing Patterns in Patients with Metastatic Urothelial Cancer Treated in the Community Practice Setting in the United States: SPEAR-Bladder (Study informing treatment Pathway dEcision in bladder cAnceR).
     Clinicoecon Outcomes Res. 2020;12:645-656.
     Abstract     Related articles   
     
     
278. WANG H, Wu JX, Chen XP, Zhang Q, et al
     Expression and Clinical Significance of MMP-28 in Bladder Cancer.
     Technol Cancer Res Treat. 2020;19:1533033820974017.
     Abstract     Related articles   
     
     
279. WANG T, Zhang D, Sun K, Wu G, et al
     The second to fourth digit ratio (2D:4D): A risk factor of bladder cancer in men.
     Early Hum Dev. 2020;152:105247.
     Abstract     Related articles   
     
     
280. WANG J, Shen C, Dong D, Zhong X, et al
     Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer.
     Int Immunopharmacol. 2020 Nov 11:107146. doi: 10.1016/j.intimp.2020.107146.
     Abstract     Related articles   
     
     
281. HURMUZ P, Ozyigit G, Kilickap S, Esen CSB, et al
     Gemcitabine based trimodality treatment in patients with muscle invasive bladder cancer: May neutrophil lymphocyte and platelet lymphocyte ratios predict outcomes?
     Urol Oncol. 2020 Nov 11. pii: S1078-1439(20)30575.
     Abstract     Related articles   
     
     
282. CHEN M, Zhang R, Lu L, Du J, et al
     LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA.
     Aging (Albany NY). 2020;12:22291-22312.
     Abstract     Related articles   
     
     
283. FISCHER-VALUCK BW, Michalski JM, Harton JG, Birtle A, et al
     Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent Chemoradiotherapy.
     Clin Genitourin Cancer. 2020 Jun 22. pii: S1558-7673(20)30144.
     Abstract     Related articles   
     
     
284. ZHU C, Zuo W, Yuan L, Su J, et al
     Comparison of Laparoendoscopic Single-Site and Laparoscopic Radical Cystectomy for Male Patients with Bladder Cancer: Perioperative and Oncologic Outcomes.
     J Laparoendosc Adv Surg Tech A. 2020 Nov 13. doi: 10.1089/lap.2020.0611.
     Abstract     Related articles   
     
     
285. KARPOV VK, Kapranov SA, Sharapov BM, Kamalov AA, et al
     [Super-selective embolisation of bladder arteries for treatment of patients with bladder tumors complicated by recurrent macrohematuria].
     Urologiia. 2020;:133-138.
     Abstract     Related articles   
     
     
286. GULIEV BG, Komyakov BK, Bolokotov RR, Al-Attar TK, et al
     [Robot-assisted radical cystectomy with neobladder formation].
     Urologiia. 2020;:54-60.
     Abstract     Related articles   
     
     
287. ZHU J, Wang H, Ma T, He Y, et al
     Identification of immune-related genes as prognostic factors in bladder cancer.
     Sci Rep. 2020;10:19695.
     Abstract     Related articles   
     
     
288. PHILYPPOV IB, Sotkis GV, Rock A, Roudbaraki M, et al
     Alterations in detrusor contractility in rat model of bladder cancer.
     Sci Rep. 2020;10:19651.
     Abstract     Related articles   
     
     
289. LIN Y, Shen Z, Tao T, Xu C, et al
     Study on the Effect of Polymer Nano-Loaded Drug System on Bladder Cancer Perfusion.
     J Nanosci Nanotechnol. 2021;21:955-961.
     Abstract     Related articles   
     
     
290. LIU B, Gao X, Han B, Chen G, et al
     Mouse Model to Explore the Therapeutic Effect of Nano-Doxorubicin Drug Delivery System on Bladder Cancer.
     J Nanosci Nanotechnol. 2021;21:914-920.
     Abstract     Related articles   
     
     
291. RABY SEM, Hoskin P, Choudhury A
     The role of palliative radiotherapy in bladder cancer: a narrative review.
     Ann Palliat Med. 2020 Nov 10. pii: apm-20-1347. doi: 10.21037/apm-20-1347.
     Abstract     Related articles   
     
     
292. HULSEN S, Lippolis E, Ferrazzi F, Otto W, et al
     High Stroma T-Cell Infiltration is Associated with Better Survival in Stage pT1 Bladder Cancer.
     Int J Mol Sci. 2020;21.
     Abstract     Related articles   
     
     
293. KIM SH, Ryu E, Kim EJ
     A Narrative Inquiry into the Adjustment Experiences of Male Bladder Cancer Survivors with a Neobladder.
     Int J Environ Res Public Health. 2020;17.
     Abstract     Related articles   
     
     
294. GAO L, Xie W, Li K, Huang G, et al
     Primitive neuroectodermal tumor of urinary bladder: A case report and literature review.
     Medicine (Baltimore). 2020;99:e23032.
     Abstract     Related articles   
     
     
295. KONG J, Lee H, Kim D, Han SK, et al
     Network-based machine learning in colorectal and bladder organoid models predicts anti-cancer drug efficacy in patients.
     Nat Commun. 2020;11:5485.
     Abstract     Related articles   
     
     
296. VUILLERMET C, Meillat H, Manceau G, Creavin B, et al
     Advanced colonic cancer with clinically suspected bladder invasion: Outcomes and prognosis from a multicentric study of 117 patients from the FRENCH research group.
     Surgery. 2020;168:786-792.
     Abstract     Related articles   
     
     
297. BABJUK M
     Unanswered Questions for Bladder Tumours Unresponsive to Bacillus Calmette-Guerin.
     Eur Urol Oncol. 2020;3:341-342.
     Abstract     Related articles   
     
     
298. JHANG S, Chen M, Chen LC
     Concurrent mullerianosis of the urinary bladder and the umbilicus presenting with umbilical bleeding: a rare case report and review of the literature.
     BMC Womens Health. 2020;20:66.
     Abstract     Related articles   
     
     
299. ZUPPONE S, Assalini C, Minici C, Bertagnoli S, et al
     The anti-tumoral potential of the saporin-based uPAR-targeting chimera ATF-SAP.
     Sci Rep. 2020;10:2521.
     Abstract     Related articles   
     
     
300. KAPLAN TM, Milman T, Shields CL
     Atypical Conjunctival Lesion Associated With a Bladder Problem.
     JAMA Ophthalmol. 2020;138:204-205.
     Abstract     Related articles   
     
     
301. WILSON C, Moseshvili E, Tacey M, Quin I, et al
     Assessment of Intrafraction Motion of the Urinary Bladder Using Magnetic Resonance Imaging (cineMRI).
     Clin Oncol (R Coll Radiol). 2020;32:101-109.
     Abstract     Related articles   
     
     
302. UCER O, Temeltas G, Gumus B, Muezzinoglu T, et al
     Comparison of pain, quality of life, lower urinary tract symptoms and sexual function between flexible and rigid cystoscopy in follow-up male patients with non muscle invasive bladder cancer: a randomized controlled cross section single blind study.
     Int J Clin Pract. 2020 Nov 27:e13853. doi: 10.1111/ijcp.13853.
     Abstract     Related articles   
     
     
303. YUAN L, Li D, Mu D, Zhang X, et al
     Combined T2 SPAIR, Dynamic Enhancement and DW Imaging Reliably Detect T Staging and Grading of Bladder Cancer With 3.0T MRI.
     Front Oncol. 2020;10:582532.
     Abstract     Related articles   
     
     
304. TIAN Y, Guan Y, Su Y, Luo W, et al
     MiR-582-5p Inhibits Bladder Cancer-Genesis by Suppressing TTK Expression.
     Cancer Manag Res. 2020;12:11933-11944.
     Abstract     Related articles   
     
     
305. HUANG X, Tao Y, Gao J, Zhou X, et al
     UBC9 coordinates inflammation affecting development of bladder cancer.
     Sci Rep. 2020;10:20670.
     Abstract     Related articles   
     
     
306. HAN Y, Liu X, Ye H, Tian Y, et al
     Lower mutant-allele tumor heterogeneity is a biomarker in FGFR3-mutant bladder cancer for better prognosis.
     World J Surg Oncol. 2020;18:310.
     Abstract     Related articles   
     
     
307. ZHU S, Xu Z, Zeng Y, Long Y, et al
     ADNP Upregulation Promotes Bladder Cancer Cell Proliferation via the AKT Pathway.
     Front Oncol. 2020;10:491129.
     Abstract     Related articles   
     
     
308. WANG HH, Chen Y, Changchien CY, Chang HH, et al
     Pharmaceutical Evaluation of Honokiol and Magnolol on Apoptosis and Migration Inhibition in Human Bladder Cancer Cells.
     Front Pharmacol. 2020;11:549338.
     Abstract     Related articles   
     
     
309. ELLA-TONGWIIS P, Lamb RM, Makanga A, Shergill I, et al
     The role of antibody expression and their association with bladder cancer recurrence: a single-centre prospective clinical-pilot study in 35 patients.
     BMC Urol. 2020;20:187.
     Abstract     Related articles   
     
     
310. PEREIRA DI, Amparo TR, Almeida TC, Costa FSF, et al
     Cytotoxic activity of butanolic extract from Sambucus nigra L. flowers in natura and vehiculated in micelles in bladder cancer cells and fibroblasts.
     Nat Prod Res. 2020 Nov 25:1-9. doi: 10.1080/14786419.2020.1851220.
     Abstract     Related articles   
     
     
311. LI D, Zhong S, Zhu Z, Jiang X, et al
     LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis.
     Pathobiology. 2020 Nov 25:1-11. doi: 10.1159/000509957.
     Abstract     Related articles   
     
     
312. GUO P, Wang L, Shang W, Chen J, et al
     Intravesical In Situ Immunostimulatory Gel for Triple Therapy of Bladder Cancer.
     ACS Appl Mater Interfaces. 2020 Nov 25. doi: 10.1021/acsami.0c15176.
     Abstract     Related articles   
     
     
313. WANG F, Ma X, Mao G, Zhang X, et al
     STAT3 enhances radiation-induced tumor migration, invasion and stem-like properties of bladder cancer.
     Mol Med Rep. 2021;23.
     Abstract     Related articles   
     
     
314. ZHAO C, Li Y, Hu X, Wang R, et al
     LncRNA HCP5 Promotes Cell Invasion and Migration by Sponging miR-29b-3p in Human Bladder Cancer.
     Onco Targets Ther. 2020;13:11827-11838.
     Abstract     Related articles   
     
     
315. RINALDETTI S, Worst TS, Rempel E, Kriegmair MC, et al
     Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer.
     Sci Rep. 2020;10:20472.
     Abstract     Related articles   
     
     
316. WU S, Xu R, Zhu X, He H, et al
     The long noncoding RNA LINC01140/miR-140-5p/FGF9 axis modulates bladder cancer cell aggressiveness and macrophage M2 polarization.
     Aging (Albany NY). 2020;12.
     Abstract     Related articles   
     
     
317. TANG C, Cai Y, Jiang H, Lv Z, et al
     LncRNA MAGI2-AS3 inhibits bladder cancer progression by targeting the miR-31-5p/TNS1 axis.
     Aging (Albany NY). 2020;12.
     Abstract     Related articles   
     
     
318. YAO DW, Song Q, He XZ
     Kinesin family member 23 (KIF23) contributes to the progression of bladder cancer cells in vitro and in vivo.
     Neoplasma. 2020 Nov 25. pii: 200803N808. doi: 10.4149/neo_2020_200803.
     Abstract     Related articles   
     
     
319. WANG W, Ding Y, Lu Q, Qi J, et al
     The development of a behaviour questionnaire for stoma self-management for persons with bladder cancer and an ileal conduit.
     J Adv Nurs. 2020 Nov 24. doi: 10.1111/jan.14662.
     Abstract     Related articles   
     
     
320. DEUKER M, Stolzenbach LF, Colla Ruvolo C, Nocera L, et al
     Bladder cancer stage and mortality: urban vs. rural residency.
     Cancer Causes Control. 2020 Nov 23. pii: 10.1007/s10552-020-01366.
     Abstract     Related articles   
     
     
321. BROUGHMAN JR, Vuong W, Mian OY
     Current Landscape and Future Directions on Bladder Sparing Approaches to Muscle-Invasive Bladder Cancer.
     Curr Treat Options Oncol. 2020;22:3.
     Abstract     Related articles   
     
     
322. KRAJEWSKI W, Moschini M, Chorbinska J, Nowak L, et al
     Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomes.
     World J Urol. 2020 Nov 23. pii: 10.1007/s00345-020-03522.
     Abstract     Related articles   
     
     
323. WANG F, Fan M, Cai Y, Zhou X, et al
     Circular RNA circRIMS1 Acts as a Sponge of miR-433-3p to Promote Bladder Cancer Progression by Regulating CCAR1 Expression.
     Mol Ther Nucleic Acids. 2020;22:815-831.
     Abstract     Related articles   
     
     
324. XIE F, Xiao X, Tao D, Huang C, et al
     circNR3C1 Suppresses Bladder Cancer Progression through Acting as an Endogenous Blocker of BRD4/C-myc Complex.
     Mol Ther Nucleic Acids. 2020;22:510-519.
     Abstract     Related articles   
     
     
325. ACHENBACH F, Rose M, Ortiz-Bruchle N, Seillier L, et al
     SWI/SNF Alterations in Squamous Bladder Cancers.
     Genes (Basel). 2020;11.
     Abstract     Related articles   
     
     
326. BANGASH M, Ather MH, Khan N, Mohammad S, et al
     Comparison Of Recurrence Rate Between "EN BLOC" Resection Of Bladder Tumour And Conventional Technique For Non-Muscle Invasive Bladder Cancer.
     J Ayub Med Coll Abbottabad. 2020;32:435-440.
     Abstract     Related articles   
     
     
327. LANDAAS EJ, Eckel AM, Wright JL, Baird GS, et al
     Application of Health Technology Assessment (HTA) to Evaluate New Laboratory Tests in a Health System: A Case Study of Bladder Cancer Testing.
     Acad Pathol. 2020;7:2374289520968225.
     Abstract     Related articles   
     
     
328. BARNETT J, Bruha M, Ozay F, Hyacinthe L, et al
     Muscle-invasive bladder cancer following radiotherapy for prostate adenocarcinoma.
     Urol Case Rep. 2020;34:101485.
     Abstract     Related articles   
     
     
329. KACEW A, Sweis RF
     FGFR3 Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer.
     Front Immunol. 2020;11:575258.
     Abstract     Related articles   
     
     
330. CARVALHO J, Lopes V, Travasso R
     Tumor Cell Invasiveness in the Initial Stages of Bladder Cancer Development - a computational study.
     Int J Numer Method Biomed Eng. 2020 Nov 22:e3417. doi: 10.1002/cnm.3417.
     Abstract     Related articles   
     
     
331. HUANG B, Huang G, Li W, Chen L, et al
     Intra-arterial chemotherapy combined with intravesical chemotherapy compared with intravesical BCG immunotherapy retrospectively in high-risk non-muscle-invasive bladder cancer after transurethral resection of the bladder tumor.
     J Cancer Res Clin Oncol. 2020 Nov 22. pii: 10.1007/s00432-020-03453.
     Abstract     Related articles   
     
     
332. WU Y, Zhang L, He S, Guan B, et al
     Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer.
     Aging (Albany NY). 2020;12.
     Abstract     Related articles   
     
     
333. XU K, Chen B, Li B, Li C, et al
     DNMT3B silencing suppresses migration and invasion by epigenetically promoting miR-34a in bladder cancer.
     Aging (Albany NY). 2020;12.
     Abstract     Related articles   
     
     
334. LOFFLER C, Mahrhold J, Fogarassy P, Beyer M, et al
     Two Immunocompromised Patients With Diffuse Alveolar Hemorrhage as a Complication of Severe Coronavirus Disease 2019.
     Chest. 2020;158:e215-e219.
     Abstract     Related articles   
     
     
335. SAGANAS C, Hewer E
     Lipidised urothelial carcinoma in pleural effusion-A case report.
     Diagn Cytopathol. 2020;48:589-590.
     Abstract     Related articles   
     
     
336. JOHNSON JT, Cherian KE, Kapoor N, Paul TV, et al
     Micturition syncope secondary to urinary bladder paraganglioma.
     BMJ Case Rep. 2020;13.
     Abstract     Related articles   
     
     
337. HUANG H, Wang T, Ahmed MG, Zhu L, et al
     Retrograde en bloc resection for non-muscle invasive bladder tumor can reduce the risk of seeding cancer cells into the peripheral circulation.
     World J Surg Oncol. 2020;18:33.
     Abstract     Related articles   
     
     
338. DEVRIM T, Atac F, Devrim AK, Balci M, et al
     The concomitant use of USP28 and p53 to predict the progression of urothelial carcinoma of the bladder.
     Pathol Res Pract. 2020;216:152774.
     Abstract     Related articles   
     
     
339. LI X, Wu T, Fu Y, Ding X, et al
     A high sensitivity background eliminated fluorescence sensing platform for hyaluronidase activity detection based on Si QDs/HA-delta-FeOOH nanoassembly.
     Biosens Bioelectron. 2020;150:111928.
     Abstract     Related articles   
     
     
340. MANNAN R, Taylor AS, Spratt DE, Chinnaiyan AM, et al
     TERT- beyond the territory: Usage of PCR-based TERT promoter assay in defining urothelial carcinoma in a case of long-standing prostatic adenocarcinoma.
     Pathol Res Pract. 2020;216:152663.
     Abstract     Related articles   
     
     
341. SAHIN C, Agridag Ucpinar B
     Idiopathic granulomatous mastitis in a male breast following intravesical Bacille Calmette-Guerin treatment.
     J Infect Public Health. 2020;13:830-832.
     Abstract     Related articles   
     
     
342. PAPPOT H, Ullen A
     Optimal Systemic Treatment of Advanced Bladder Cancer-A Moving Target.
     Cancers (Basel). 2020;12.
     Abstract     Related articles   
     
     
343. KOTI M, Berman DM, Siemens DR, Lange D, et al
     Building a Canadian Translational Bladder Cancer Research Network.
     Can Urol Assoc J. 2020;14:E475-E481.
     Abstract     Related articles   
     
     
344. FACCHINI G, Cavaliere C, Romis L, Mordente S, et al
     Advanced/metastatic bladder cancer: current status and future directions.
     Eur Rev Med Pharmacol Sci. 2020;24:11536-11552.
     Abstract     Related articles   
     
     
345. QIU D, Zhu Y, Cong Z
     YAP Triggers Bladder Cancer Proliferation by Affecting the MAPK Pathway.
     Cancer Manag Res. 2020;12:12205-12214.
     Abstract     Related articles   
     
     
346. SIKDER RK, Ellithi M, Uzzo RN, Weader D, et al
     Differential effects of clinically-relevant N- vs C-terminal truncating CDKN1A mutations on cisplatin sensitivity in bladder cancer.
     Mol Cancer Res. 2020 Dec 3. pii: 1541-7786.MCR-19-1200.
     Abstract     Related articles   
     
     
347. YAMAMOTO T, Matsuzaki K, Katayama K, Tei N, et al
     [Primary Pulmonary Cryptococcosis Mimicking Lung Metastases of Bladder Cancer : A Case Report].
     Hinyokika Kiyo. 2020;66:393-395.
     Abstract     Related articles   
     
     
348. SHEN D, Zhang Y, Zheng Q, Yu S, et al
     A Competing Endogenous RNA Network and an 8-lncRNA Prognostic Signature Identify MYO16-AS1 as an Oncogenic lncRNA in Bladder Cancer.
     DNA Cell Biol. 2020 Dec 2. doi: 10.1089/dna.2020.6014.
     Abstract     Related articles   
     
     
349. WANG Z, Chen J, Yang L, Cao M, et al
     Single-Cell Sequencing-Enabled Hexokinase 2 Assay for Noninvasive Bladder Cancer Diagnosis and Screening by Detecting Rare Malignant Cells in Urine.
     Anal Chem. 2020 Dec 3. doi: 10.1021/acs.analchem.0c04282.
     Abstract     Related articles   
     
     
350. CARANDO R, Ludovico GM, Zazzara M, Zamboni S, et al
     Precision medicine in localized bladder cancer: Personalizing therapies to improve outcomes.
     Arch Esp Urol. 2021;73:1016-1022.
     Abstract     Related articles   
     
     
351. CAMPANARIO PEREZ R, Campanario Perez F
     [Current treatment options and future perspectives on first line metastatic bladder cancer.]
     Arch Esp Urol. 2021;73:996-1006.
     Abstract     Related articles   
     
     
352. DOMINGUEZ ESCRIG JL
     [Muscle invasive bladder cancer and bladder preservation protocols. Where are we?]
     Arch Esp Urol. 2021;73:986-995.
     Abstract     Related articles   
     
     
353. OSANTO S, Alvarez Gomez de Segura C
     Neoadjuvant and adjuvant treatments in muscle-invasive bladder cancer: Where are we?
     Arch Esp Urol. 2021;73:971-985.
     Abstract     Related articles   
     
     
354. LOIZAGA IRIARTE A, Senarriaga Ruiz de la Illa N, Martin Bazaco J, Rabade Ferreiro A, et al
     [Background historical views of systemic treatment for muscle invasive bladder cancer.]
     Arch Esp Urol. 2021;73:954-960.
     Abstract     Related articles   
     
     
355. CALIFANO G, Ouzaid I, Verze P, Stivalet N, et al
     New immunotherapy treatments in non-muscle invasive bladder cancer.
     Arch Esp Urol. 2021;73:945-953.
     Abstract     Related articles   
     
     
356. VALES-GOMEZ M, Esteso G, Felgueres MJ, Huete-Carrasco J, et al
     [Bladder cancer immunological background and biomarkers.]
     Arch Esp Urol. 2021;73:895-905.
     Abstract     Related articles   
     
     
357. CARBALLIDO JA, Vazquez Alba D, Rodriguez Monsalve M
     [Local and systhemic immunotherapy for bladder cancer: from bench to bedside.]
     Arch Esp Urol. 2021;73:879-894.
     Abstract     Related articles   
     
     
358. ROZANEC JJ, Secin FP
     [Epidemiology, etiology and prevention of bladder cancer.]
     Arch Esp Urol. 2021;73:872-878.
     Abstract     Related articles   
     
     
359. TRAN L, Xiao JF, Agarwal N, Duex JE, et al
     Advances in bladder cancer biology and therapy.
     Nat Rev Cancer. 2020 Dec 2. pii: 10.1038/s41568-020-00313.
     Abstract     Related articles   
     
     
360. HURLE R, Contieri R, Casale P, Morenghi E, et al
     Midterm follow-up (3 years) confirms and extends short-term results of intravesical gemcitabine as bladder-preserving treatment for non-muscle-invasive bladder cancer after BCG failure.
     Urol Oncol. 2020 Oct 22. pii: S1078-1439(20)30439.
     Abstract     Related articles   
     
     
361. EHLERS M, Bjurlin M, Gore J, Pruthi R, et al
     A national cross-sectional survey of financial toxicity among bladder cancer patients.
     Urol Oncol. 2020 Oct 22. pii: S1078-1439(20)30467.
     Abstract     Related articles   
     
     
362. YING X, Jiang X, Zhang H, Liu B, et al
     Programmable N6-methyladenosine modification of CDCP1 mRNA by RCas9-methyltransferase like 3 conjugates promotes bladder cancer development.
     Mol Cancer. 2020;19:169.
     Abstract     Related articles   
     
     
363. KOUTSOUKOS K, Andrikopoulou A, Dedes N, Zagouri F, et al
     Clinical Perspectives of ERCC1 in Bladder Cancer.
     Int J Mol Sci. 2020;21.
     Abstract     Related articles   
     
     
364. POLO-ALONSO E, Kuk C, Guruli G, Paul AK, et al
     Trimodal therapy in muscle invasive bladder cancer management.
     Minerva Urol Nefrol. 2020;72:650-662.
     Abstract     Related articles   
     
     
365. LEE LJ, Kwon CS, Forsythe A, Mamolo CM, et al
     Humanistic and Economic Burden of Non-Muscle Invasive Bladder Cancer: Results of Two Systematic Literature Reviews.
     Clinicoecon Outcomes Res. 2020;12:693-709.
     Abstract     Related articles   
     
     
366. GUO Z, Gu C, Li S, Gan S, et al
     Incidence and risk factors of suicide among patients diagnosed with bladder cancer: A systematic review and meta-analysis.
     Urol Oncol. 2020 Nov 28. pii: S1078-1439(20)30611.
     Abstract     Related articles   
     
     
367. MUN JY, Baek SW, Park WY, Kim WT, et al
     E2F1 Promotes Progression of Bladder Cancer by Modulating RAD54L Involved in Homologous Recombination Repair.
     Int J Mol Sci. 2020;21.
     Abstract     Related articles   
     
     
368. JIANG W, Zhu D, Wang C, Zhu Y, et al
     Tumor suppressing effects of tristetraprolin and its small double-stranded RNAs in bladder cancer.
     Cancer Med. 2020 Dec 1. doi: 10.1002/cam4.3622.
     Abstract     Related articles   
     
     
369. MOKOU M, Lygirou V, Angelioudaki I, Paschalidis N, et al
     A Novel Pipeline for Drug Repurposing for Bladder Cancer Based on Patients' Omics Signatures.
     Cancers (Basel). 2020;12.
     Abstract     Related articles   
     
     
370. ZOU Y, Du Y, Cheng C, Deng X, et al
     FAT10 promotes the progression of bladder cancer by upregulating HK2 through the EGFR/AKT pathway.
     Exp Cell Res. 2020;398:112401.
     Abstract     Related articles   
     
     
371. BOORJIAN SA, Alemozaffar M, Konety BR, Shore ND, et al
     Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
     Lancet Oncol. 2020 Nov 27. pii: S1470-2045(20)30540.
     Abstract     Related articles   
     
     
372. KULKARNI GS
     Nadofaragene firadenovec: a new gold standard for BCG-unresponsive bladder cancer?
     Lancet Oncol. 2020 Nov 27. pii: S1470-2045(20)30586.
     Abstract     Related articles   
     
     
373. TOUSSIROT E, Guichard G, Saas P
     Sustained remission of ankylosing spondylitis following intravesical Bacillus Calmette et Guerin immunotherapy for bladder cancer.
     Clin Exp Rheumatol. 2020 Nov 22. pii: 16275.
     Abstract     Related articles   
     
     
374. ZAGHLOUL MS, Zaghloul TM, Bishr MK, Baumann BC, et al
     Urinary schistosomiasis and the associated bladder cancer: update.
     J Egypt Natl Canc Inst. 2020;32:44.
     Abstract     Related articles   
     
     
375. TANG X, Cao Y, Liu J, Wang S, et al
     Diagnostic Value of Inflammatory Factors in Pathology of Bladder Cancer Patients.
     Front Mol Biosci. 2020;7:575483.
     Abstract     Related articles   
     
     
376. ZANG Z, Lim YK, Chan YH, Raman L, et al
     Polymorphism in autophagy gene ATG2B is not associated with bladder cancer recurrence after intravesical Bacillus Calmette-Guerin (BCG) immunotherapy in Asian patients.
     Urol Oncol. 2020 Nov 26. pii: S1078-1439(20)30602.
     Abstract     Related articles   
     
     
377. HAN HS, Jeong S, Kim H, Kim HD, et al
     TOX-expressing terminally exhausted tumor-infiltrating CD8(+) T cells are reinvigorated by co-blockade of PD-1 and TIGIT in bladder cancer.
     Cancer Lett. 2020 Nov 27. pii: S0304-3835(20)30633.
     Abstract     Related articles   
     
     
378. MAGER LF, Burkhard R, Pett N, Cooke NCA, et al
     Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy.
     Science. 2020;369:1481-1489.
     Abstract     Related articles   
     
     
379. SHAN H, Tian W, Hong Y, Xu B, et al
     Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma complicated with aristolochic acid nephropathy after radical nephroureterectomy.
     BMC Complement Med Ther. 2020;20:166.
     Abstract     Related articles   
     
     
380. SEFIK E, Celik S, Gunlusoy B, Basmaci I, et al
     The significance of preoperative estimated glomerular filtration rate on survival outcomes in patients who underwent radical cystectomy and non-continent urinary diversion.
     Int Braz J Urol. 2020;46:566-574.
     Abstract     Related articles   
     
     
381. BENAMRAN D, Phe V, Drouin SJ, Perrot O, et al
     Functional outcomes obtained with intracorporeal neobladder after robotic radical cystectomy for cancer: a narrative review.
     J Robot Surg. 2020;14:813-820.
     Abstract     Related articles   
     
     
382. KAZAKOVA V, Kadamkulam Syriac A, Perepletchikov A, Sweeney AT, et al
     Regional metastatic paraganglioma of the bladder: a rare cause of myocardial infarction, reversible cardiomyopathy and an intracardiac thrombus.
     BMJ Case Rep. 2020;13.
     Abstract     Related articles   
     
     
383. MANTICA G, Smelzo S, Ambrosini F, Tappero S, et al
     Port-site metastasis and atypical recurrences after robotic-assisted radical cystectomy (RARC): an updated comprehensive and systematic review of current evidences.
     J Robot Surg. 2020;14:805-812.
     Abstract     Related articles   
     
     
384. ANBARDAR MH, Monjazeb R
     Reclassification of urinary cytology regarding The Paris System for Reporting Urinary Cytology with cytohistological correlation demonstrates high sensitivity for high-grade urothelial carcinoma.
     Diagn Cytopathol. 2020;48:446-452.
     Abstract     Related articles   
     
     
385. SHAKER D
     Anterior enterocele: a cause of recurrent prolapse after radical cystectomy.
     Int Urogynecol J. 2020;31:219-220.
     Abstract     Related articles   
     
     
386. WASSERMAN NF
     Commentary: Ureteral pseudodiverticulosis is diagnosable on computed tomography.
     Abdom Radiol (NY). 2020;45:3819-3820.
     Abstract     Related articles   
     
     
387. WANG EY, Larsson U, Gardmark T, Malmstrom PU, et al
     Radical cystectomy compared to intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer - is there a long-term survival difference? A Swedish nationwide analysis.
     Scand J Urol. 2020 Dec 11:1-7. doi: 10.1080/21681805.2020.1851763.
     Abstract     Related articles   
     
     
388. CHESTNUT C, Subramaniam D, Dandawate P, Padhye S, et al
     Targeting Major Signaling Pathways of Bladder Cancer with Phytochemicals: A Review.
     Nutr Cancer. 2020 Dec 11:1-23. doi: 10.1080/01635581.2020.1856895.
     Abstract     Related articles   
     
     
389. ARIAFAR A, Vahidi Y, Fakhimi M, Asadollahpour A, et al
     Prognostic significance of CD4-positive regulatory T cells in tumor draining lymph nodes from patients with bladder cancer.
     Heliyon. 2020;6:e05556.
     Abstract     Related articles   
     
     
390. VITTI GAMBIM V, Laufer-Amorim R, Fonseca Alves RH, Grieco V, et al
     A Comparative Meta-Analysis and in silico Analysis of Differentially Expressed Genes and Proteins in Canine and Human Bladder Cancer.
     Front Vet Sci. 2020;7:558978.
     Abstract     Related articles   
     
     
391. WHANG YM, Yoon DH, Hwang GY, Yoon H, et al
     Liposome-Encapsulated Bacillus Calmette-Guerin Cell Wall Skeleton Enhances Antitumor Efficiency for Bladder Cancer In Vitro and In Vivo via Induction of AMP-Activated Protein Kinase.
     Cancers (Basel). 2020;12.
     Abstract     Related articles   
     
     
392. TINAY I, Baltaci S, Demirdag C, Akdogan B, et al
     Ta Grade 3/High Grade Non-Invasive Bladder Cancer: Should We Perform A Second TUR?
     Int J Clin Pract. 2020 Dec 10:e13924. doi: 10.1111/ijcp.13924.
     Abstract     Related articles   
     
     
393. SOARES A, Mesquita A, Pinto J, Magalhaes H, et al
     Pseudoprogression or unexpected favorable response to third-line therapy: a challenging metastatic bladder cancer case.
     Porto Biomed J. 2020;5:e58.
     Abstract     Related articles   
     
     
394. SOAVE A, Kluwe L, Yu H, Rink M, et al
     Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy.
     Sci Rep. 2020;10:21562.
     Abstract     Related articles   
     
     
395. KOGUCHI D, Matsumoto K, Hirayama T, Moroo S, et al
     Impact of maintenance therapy using a half dose of the bacillus Calmette-Guerin Tokyo strain on recurrence of intermediate and high-risk nonmuscle invasive bladder cancer: a retrospective single-center study.
     BMC Urol. 2020;20:194.
     Abstract     Related articles   
     
     
396. FURUYA H, Tabula L, Lee R, Kralovec P, et al
     Analytical validation of ONCURIA a multiplex bead-based immunoassay for the non-invasive bladder cancer detection.
     Pract Lab Med. 2020;22:e00189.
     Abstract     Related articles   
     
     
397. KHAN K, Quispe C, Javed Z, Iqbal MJ, et al
     Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K/Akt/mTOR pathway: go four better to treat bladder cancer.
     Cancer Cell Int. 2020;20:560.
     Abstract     Related articles   
     
     
398. SHEN C, Liu J, Wang L, Liang Z, et al
     Identification of metabolism-associated genes and construction of a prognostic signature in bladder cancer.
     Cancer Cell Int. 2020;20:538.
     Abstract     Related articles   
     
     
399. PAPADIMITRIOU MA, Avgeris M, Levis P, Papasotiriou EC, et al
     tRNA-Derived Fragments (tRFs) in Bladder Cancer: Increased 5'-tRF-LysCTT Results in Disease Early Progression and Patients' Poor Treatment Outcome.
     Cancers (Basel). 2020;12.
     Abstract     Related articles   
     
     
400. WANG L, Yang C, Chu M, Wang ZW, et al
     Cdc20 induces the radioresistance of bladder cancer cells by targeting FoxO1 degradation.
     Cancer Lett. 2020 Dec 5. pii: S0304-3835(20)30650.
     Abstract     Related articles   
     
     
401. TONG H, Li T, Gao S, Yin H, et al
     An Epithelial-Mesenchymal Transition-Related Long Noncoding RNA Signature Correlates With The Prognosis And Progression In Bladder Cancer Patients.
     Biosci Rep. 2020 Dec 8. pii: 227198. doi: 10.1042/BSR20203944.
     Abstract     Related articles   
     
     
402. LIU B, Gao W, Sun W, Li L, et al
     Promoting roles of long non-coding RNA FAM83H-AS1 in bladder cancer growth, metastasis, and angiogenesis through the c-Myc-mediated ULK3 upregulation.
     Cell Cycle. 2020 Dec 8:1-17. doi: 10.1080/15384101.2020.1850971.
     Abstract     Related articles   
     
     
403. KANG W, Wang Q, Dai Y, Wang H, et al
     Hypomethylation of PlncRNA-1 promoter enhances bladder cancer progression through the miR-136-5p/Smad3 axis.
     Cell Death Dis. 2020;11:1038.
     Abstract     Related articles   
     
     
404. LIU Y, Zheng H, Xu X, Zhang X, et al
     The invasion depth measurement of bladder cancer using T2-weighted magnetic resonance imaging.
     Biomed Eng Online. 2020;19:92.
     Abstract     Related articles   
     
     
405. OSSICK MV, Assalin HB, Kiehl IGA, Salustiano ACC, et al
     Carcinogenesis and Bacillus Calmette-Guerin (BCG) Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer under Tryptophan and Thymine Supplementation.
     Nutr Cancer. 2020 Dec 8:1-8. doi: 10.1080/01635581.2020.1856389.
     Abstract     Related articles   
     
     
406. OEHR P, Ecke T
     Establishment and Characterization of an Empirical Biomarker SS/PV-ROC Plot Using Results of the UBC((R)) Rapid Test in Bladder Cancer.
     Entropy (Basel). 2020;22.
     Abstract     Related articles   
     
     
407. KORKES F, Maluf F
     Increasing costs from bladder cancer in the Brazilian Health System: the role of establishing public health policies.
     Int Braz J Urol. 2021;47:443-447.
     Abstract     Related articles   
     
     
408. KORKES F, Timoteo F, Ferrari KL, Reis LO, et al
     Bacillus Calmette-Guerin (BCG) Brazilian Backstage in Bladder Cancer.
     Int Braz J Urol. 2021;47:232-236.
     Abstract     Related articles   
     
     
409. KOOL R, Marcq G, El-Achkar A, Mansure JJ, et al
     Refining assessment of response to radiation-based therapy for muscle-invasive bladder cancer: Is post-treatment tumor bed biopsy always necessary?
     Urol Oncol. 2020 Oct 23. pii: S1078-1439(20)30473.
     Abstract     Related articles   
     
     
410. WU S, Deng H, He H, Xu R, et al
     The circ_0004463/miR-380-3p/FOXO1 axis modulates mitochondrial respiration and bladder cancer cell apoptosis.
     Cell Cycle. 2020 Dec 7:1-18. doi: 10.1080/15384101.2020.1852746.
     Abstract     Related articles   
     
     
411. JOCHEMS SHJ, Wesselius A, Zeegers MP
     Erratum to: Total Fluid Intake and the Risk of Recurrence in Patients with Non-Muscle Invasive Bladder Cancer: A Prospective Cohort Study.
     Bladder Cancer. 2020;6:401.
     Abstract     Related articles   
     
     
412. CHEN Y, Zhang W, Shen L, Kadier A, et al
     Downregulation of Long Noncoding RNA LUCAT1 Suppresses the Migration and Invasion of Bladder Cancer by Targeting miR-181c-5p.
     Biomed Res Int. 2020;2020:4817608.
     Abstract     Related articles   
     
     
413. CHE W, Ye S, Cai A, Cui X, et al
     CRISPR-Cas13a Targeting the Enhancer RNA-SMAD7e Inhibits Bladder Cancer Development Both in vitro and in vivo.
     Front Mol Biosci. 2020;7:607740.
     Abstract     Related articles   
     
     
414. CHEN B, Bu R, Xu X
     Expression of Tight Junction Proteins Is Altered in Bladder Cancer.
     Anal Cell Pathol (Amst). 2020;2020:6341256.
     Abstract     Related articles   
     
     
415. LIN G, Guo B, Wei Y, Lan T, et al
     Impact of Long Non-coding RNAs Associated With Microenvironment on Survival for Bladder Cancer Patients.
     Front Genet. 2020;11:567200.
     Abstract     Related articles   
     
     
416. CHO CJ, Yu CP, Wu CL, Ho JY, et al
     Decreased drug resistance of bladder cancer using phytochemicals treatment.
     Kaohsiung J Med Sci. 2020 Oct 14. doi: 10.1002/kjm2.12306.
     Abstract     Related articles   
     
     
417. TANG C, Wang M, Dai Y, Wei X, et al
     Kruppel-like factor 12 suppresses bladder cancer growth through transcriptionally inhibition of enolase 2.
     Gene. 2020 Dec 3:145338. doi: 10.1016/j.gene.2020.145338.
     Abstract     Related articles   
     
     
418. GURBUZ BC, Topal CS, Sobay R, Alkurt G, et al
     Molecular and immunohistochemical evaluation of BAP-1 antibody in bladder cancer and comparison with luminal-basal subtyping.
     Pathol Res Pract. 2020;217:153308.
     Abstract     Related articles   
     
     
419. WU G, Weng W, Xia P, Yan S, et al
     Wnt signalling pathway in bladder cancer.
     Cell Signal. 2020 Dec 16:109886. doi: 10.1016/j.cellsig.2020.109886.
     Abstract     Related articles   
     
     
420. PIAO XM, Kang HW, Jeong P, Byun YJ, et al
     A prognostic immune predictor, HLA-DRA, plays diverse roles in non-muscle invasive and muscle invasive bladder cancer.
     Urol Oncol. 2020 Dec 15. pii: S1078-1439(20)30603.
     Abstract     Related articles   
     
     
421. DONG ZC, Zhang D, Zhang XX, Yao ZQ, et al
     MiR-155 affects proliferation and apoptosis of bladder cancer cells by regulating GSK-3beta/beta-catenin pathway.
     Eur Rev Med Pharmacol Sci. 2020;24:11990.
     Abstract     Related articles   
     
     
422. LI MZ, Lai DH, Zhao HB, Chen Z, et al
     SOCS3 overexpression enhances ADM resistance in bladder cancer T24 cells.
     Eur Rev Med Pharmacol Sci. 2020;24:11985.
     Abstract     Related articles   
     
     
423. ROUPRET M, Morere JF, Touboul C, Lhomel C, et al
     Knowledge of bladder cancer in the French population: results of the EDIFICE 6 survey.
     Eur J Cancer Care (Engl). 2020 Dec 17:e13392. doi: 10.1111/ecc.13392.
     Abstract     Related articles   
     
     
424. MAO F, Niu XB, Gu S, Ji L, et al
     CTLA-4 +49A/G Polymorphism Increases the Susceptibility to Bladder Cancer in Chinese Han Participants: A Case-Control Study.
     Dis Markers. 2020;2020:8143158.
     Abstract     Related articles   
     
     
425. NG K, Vinnakota K, Sharma A, Kelly J, et al
     Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era.
     Nat Rev Urol. 2020 Dec 17. pii: 10.1038/s41585-020-00419.
     Abstract     Related articles   
     
     
426. MO Q, Li R, Adeegbe DO, Peng G, et al
     Integrative multi-omics analysis of muscle-invasive bladder cancer identifies prognostic biomarkers for frontline chemotherapy and immunotherapy.
     Commun Biol. 2020;3:784.
     Abstract     Related articles   
     
     
427. YAMASHITA S, Iwahashi Y, Miyai H, Iguchi T, et al
     Myosteatosis as a novel prognostic biomarker after radical cystectomy for bladder cancer.
     Sci Rep. 2020;10:22146.
     Abstract     Related articles   
     
     
428. WU S, Nitschke K, Worst TS, Fierek A, et al
     Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer.
     J Exp Clin Cancer Res. 2020;39:288.
     Abstract     Related articles   
     
     
429. LU K, Wang F, Ma B, Cao W, et al
     Teratogenic Toxicity Evaluation of Bladder Cancer Specific Oncolytic Adenovirus on Mice.
     Curr Gene Ther. 2020 Dec 17. pii: CGT-EPUB-112514.
     Abstract     Related articles   
     
     
430. MIYATA Y, Matsuo T, Ohba K, Mitsunari K, et al
     Present Status, Limitations and Future Directions of Treatment Strategies Using Fucoidan-Based Therapies in Bladder Cancer.
     Cancers (Basel). 2020;12.
     Abstract     Related articles   
     
     
431. WANG C, Ding Y, Liu Y, Zhang Q, et al
     Identification of Mutated Peptides in Bladder Cancer From Exomic Sequencing Data Reveals Negative Correlation Between Mutation-Specific Immunoreactivity and Inflammation.
     Front Immunol. 2020;11:576603.
     Abstract     Related articles   
     
     
432. QING L, Gu P, Liu M, Shen J, et al
     Extracellular Matrix-Related Six-lncRNA Signature as a Novel Prognostic Biomarker for Bladder Cancer.
     Onco Targets Ther. 2020;13:12521-12538.
     Abstract     Related articles   
     
     
433. WANG Y, Zhang L, Wei N, Sun Y, et al
     Silencing LINC00482 inhibits tumor-associated inflammation and angiogenesis through down-regulation of MMP-15 via FOXA1 in bladder cancer.
     Aging (Albany NY). 2020;12.
     Abstract     Related articles   
     
     
434. LI H, Lu H, Cui W, Huang Y, et al
     A TP53-based immune prognostic model for muscle-invasive bladder cancer.
     Aging (Albany NY). 2020;12.
     Abstract     Related articles   
     
     
435. ALHALABI O, Hahn AW, Msaouel P, Andreev-Drakhlin AY, et al
     Molecular profiling of metastatic bladder cancer early-phase clinical trial participants predicts patient outcomes.
     Mol Cancer Res. 2020 Dec 15. pii: 1541-7786.MCR-20-0751.
     Abstract     Related articles   
     
     
436. PASQUALE V, Ducci G, Campioni G, Ventrici A, et al
     Profiling and Targeting of Energy and Redox Metabolism in Grade 2 Bladder Cancer Cells with Different Invasiveness Properties.
     Cells. 2020;9.
     Abstract     Related articles   
     
     
437. WHONGSIRI P, Goering W, Lautwein T, Hader C, et al
     Many Different LINE-1 Retroelements Are Activated in Bladder Cancer.
     Int J Mol Sci. 2020;21.
     Abstract     Related articles   
     
     
438. MANINI C, Lopez JI
     Unusual Faces of Bladder Cancer.
     Cancers (Basel). 2020;12.
     Abstract     Related articles   
     
     
439. MIRANDA MA, Marcato PD, Mondal A, Chowdhury N, et al
     Cytotoxic and chemosensitizing effects of glycoalkaloidic extract on 2D and 3D models using RT4 and patient derived xenografts bladder cancer cells.
     Mater Sci Eng C Mater Biol Appl. 2021;119:111460.
     Abstract     Related articles   
     
     
440. LU J, Zhang Y, Wu C, Chu C, et al
     Impact of immunohistochemistry-based molecular subtype on predicting chemotherapy response and survival in patients with T1 stage bladder cancer after bladder-preserving treatment.
     Jpn J Clin Oncol. 2020 Dec 15. pii: 6034414. doi: 10.1093.
     Abstract     Related articles   
     
     
441. GUO B, Liu M
     The role of radical cystectomy in patients with T1 variant histology bladder cancer.
     Eur J Surg Oncol. 2020 Dec 10. pii: S0748-7983(20)31209.
     Abstract     Related articles   
     
     
442. GUO B, Liu M
     Survival differences by ethnicity among patients diagnosed with bladder cancer.
     J Transl Med. 2020;18:486.
     Abstract     Related articles   
     
     
443. ZHAO F, Vakhrusheva O, Markowitsch SD, Slade KS, et al
     Artesunate Impairs Growth in Cisplatin-Resistant Bladder Cancer Cells by Cell Cycle Arrest, Apoptosis and Autophagy Induction.
     Cells. 2020;9.
     Abstract     Related articles   
     
     
444. VLAMING M, Kiemeney LALM, van der Heijden AG
     Survival after radical cystectomy: Progressive versus De novo muscle invasive bladder cancer.
     Cancer Treat Res Commun. 2020;25:100264.
     Abstract     Related articles   
     
     
445. RICHTERS A, Mehra N, Meijer RP, Boormans JL, et al
     Utilization of systemic treatment for metastatic bladder cancer in everyday practice: Results of a nation-wide population-based cohort study.
     Cancer Treat Res Commun. 2020;25:100266.
     Abstract     Related articles   
     
     
446. HUDDART R, Hafeez S, Lewis R, McNair H, et al
     Clinical outcomes of a randomised trial of adaptive plan of the day treatment in patients receiving ultra-hypofractionated weekly radiotherapy for bladder cancer.
     Int J Radiat Oncol Biol Phys. 2020 Dec 11. pii: S0360-3016(20)34640.
     Abstract     Related articles   
     
     
447. SONG RX, Zhu GJ, Dong CM, Wang ZP, et al
     Novel Diagnostic and Prognostic Value of Circulating miR-18a in the Plasma of Patients with Bladder Cancer.
     Clin Biochem. 2020 Dec 11. pii: S0009-9120(20)30921.
     Abstract     Related articles   
     
     
448. HOMAMI A, Ataei Kachoei Z, Asgarie M, Ghazi F, et al
     Analysis of FGFR3 and HRAS genes in patients with bladder cancer.
     Med J Islam Repub Iran. 2020;34:108.
     Abstract     Related articles   
     
     
449. TONG L, Yang H, Xiong W, Tang G, et al
     Circ_100984-miR-432-3p axis regulated c-Jun/YBX-1/beta-catenin feedback loop promotes bladder cancer progression.
     Cancer Sci. 2020 Dec 14. doi: 10.1111/cas.14774.
     Abstract     Related articles   
     
     
450. AWADALLA A, Mortada WI, Abol-Enein H, Shokeir AA, et al
     Correlation between blood levels of cadmium and lead and the expression of microRNA-21 in Egyptian bladder cancer patients.
     Heliyon. 2020;6:e05642.
     Abstract     Related articles   
     
     
451. SHI YR, Xiong K, Ye X, Yang P, et al
     Development of a prognostic signature for bladder cancer based on immune-related genes.
     Ann Transl Med. 2020;8:1380.
     Abstract     Related articles   
     
     
452. AGRAWAL V, Bharti N, Pandey R
     Human epidermal growth factor receptor 2 (HER2) gene amplification in non-muscle invasive urothelial bladder cancers: Identification of patients for targeted therapy.
     Arab J Urol. 2020;18:267-272.
     Abstract     Related articles   
     
     
453. LI W, Zhang Y, Li Y, Cao Y, et al
     Profiling Analysis Reveals the Crucial Role of the Endogenous Peptides in Bladder Cancer Progression.
     Onco Targets Ther. 2020;13:12443-12455.
     Abstract     Related articles   
     
     
454. MENG L, Xing Z, Guo Z, Liu Z, et al
     LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progression.
     Cell Death Dis. 2020;11:1063.
     Abstract     Related articles   
     
     
455. DI GIANFRANCESCO L, Ragonese M, Palermo G, Sacco E, et al
     Second-Line Conservative Device-Assisted Intravesical Treatment in Selected Patients With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer.
     Clin Genitourin Cancer. 2020 Nov 13. pii: S1558-7673(20)30252.
     Abstract     Related articles   
     
     
456. LAZEBNIK T, Aaroni N, Bunimovich-Mendrazitsky S
     PDE based geometry model for BCG immunotherapy of bladder cancer.
     Biosystems. 2020;200:104319.
     Abstract     Related articles   
     
     
457. JUNG A, Crandell JL, Nielsen ME, Mayer DK, et al
     Post-traumatic stress disorder symptoms in non-muscle-invasive bladder cancer survivors: A population-based study.
     Urol Oncol. 2020 Dec 8. pii: S1078-1439(20)30621.
     Abstract     Related articles   
     
     
458. DEGENER S, Dreger NM, Godde D, Dotse J, et al
     The natural history of muscle-invasive bladder cancer in geriatric patients undergoing transurethral resection only: Outcome and cost.
     Urol Oncol. 2020 Dec 8. pii: S1078-1439(20)30619.
     Abstract     Related articles   
     
     
459. HORIGUCHI H, Hatakeyama S, Yoneyama T, Yoneyama MS, et al
     Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer.
     Urol Oncol. 2020 Dec 8. pii: S1078-1439(20)30616.
     Abstract     Related articles   
     
     
460. CABAS P, Rizzo M, Giuffre M, Antonello RM, et al
     BCG infection (BCGitis) following intravesical instillation for bladder cancer and time interval between treatment and presentation: A systematic review.
     Urol Oncol. 2020 Dec 8. pii: S1078-1439(20)30624.
     Abstract     Related articles   
     
     
461. AMIRI M, Heshmatollah S, Esmaeilnasab N, Khoubi J, et al
     Survival rate of patients with bladder cancer and its related factors in Kurdistan Province (2013-2018): a population-based study.
     BMC Urol. 2020;20:195.
     Abstract     Related articles   
     
     
462. KORKES F, Cunha FTS, Nascimento MP, Rodrigues AFS, et al
     Mortality after radical cystectomy is strongly related to the institution's volume of surgeries.
     Einstein (Sao Paulo). 2020;18:eAO5628.
     Abstract     Related articles   
     
     
463. TAKEI K, Otsuki Y
     [Squamous Cell Papilloma of the Urinary Bladder].
     Hinyokika Kiyo. 2020;66:403-406.
     Abstract     Related articles   
     
     
464. TANI M, Tsutahara K, Inoguchi S, Oka T, et al
     [Rituximab Chemotherapy for Primary Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma of the Urinary Bladder : A Case Report].
     Hinyokika Kiyo. 2020;66:397-401.
     Abstract     Related articles   
     
     
465. YAMAMICHI G, Nakata W, Yoshimura A, Tsujimura G, et al
     [Usefulness of Fluorescent Urine Cytology in the Diagnosis of Urothelial Carcinoma].
     Hinyokika Kiyo. 2020;66:377-381.
     Abstract     Related articles   
     
     
466. ISHIKAWA T, Kanaki T, Yamamoto A, Yamanaka Y, et al
     [A Case of Metachronous Bilateral Epididymal Tuberculosis after BCG Instillation Therapy].
     Hinyokika Kiyo. 2020;66:363-367.
     Abstract     Related articles   
     
     
467. SANO T, Muramaki M, Nakayama S, Den H, et al
     [A Case of a Young Patient with Nested Variant of Urothelial Carcinoma of the Bladder].
     Hinyokika Kiyo. 2020;66:347-349.
     Abstract     Related articles   
     
     
468. QUESADA-OLARTE J, Alvarez-Maestro M, Gomez-Rivas J, Toribio-Vazquez C, et al
     Organ-sparing cystectomy techniques: Functional and oncological outcomes, review and current recommendations.
     Arch Esp Urol. 2020;73:961-970.
     Abstract     Related articles   
     
     
469. GUERRERO-RAMOS F, Rodriguez-Antolin A
     [New endovesical chemotherapy and means of administration: EMD, HIVEC, Synergo, Unithermia.]
     Arch Esp Urol. 2020;73:934-944.
     Abstract     Related articles   
     
     
470. LENDINEZ-CANO G, Rivero-Belenchon I, Medina-Lopez RA
     [Recurrence and progression after BCG.]
     Arch Esp Urol. 2020;73:929-933.
     Abstract     Related articles   
     
     
471. RODRIGUEZ FABA O, Huguet Perez J, Pisano F, Parada R, et al
     [BCG Immunotherapy, past, present and future.]
     Arch Esp Urol. 2020;73:918-928.
     Abstract     Related articles   
     
     
472. COZAR-OLMO JM
     [Editorial: El cancer vesical, un tumor urologico.]
     Arch Esp Urol. 2020;73:869-871.
     Abstract     Related articles   
     
     
473. ADANS-DESTER G, Grobet-Jeandin E, Roosendaal A, Iselin C, et al
     [Robot-assisted cystectomy and urinary diversion, new standard of care ? What are the benefits ?]
     Rev Med Suisse. 2020;16:2339-2342.
     Abstract     Related articles   
     
     
474. MURTHY PB, Campbell RA, Lee BH
     Intracorporeal Urinary Diversion in Robotic Radical Cystectomy.
     Urol Clin North Am. 2021;48:51-70.
     Abstract     Related articles   
     
     
475. MERINO-MATEO L, Tordable Ojeda C, Cabezali Barbancho D, Gomez Fraile A, et al
     Impact of the COVID-19 pandemic on the surgical activity of Pediatric Urology: analysis of postoperative complications according to the Clavien-Dindo classification.
     Actas Urol Esp. 2020;44:659-664.
     Abstract     Related articles   
     
     
476. CARTIER N, Chesnay A, N'diaye D, Thorey C, et al
     Candida nivariensis: Identification strategy in mycological laboratories.
     J Mycol Med. 2020;30:101042.
     Abstract     Related articles   
     
     
477. ALCANTARA-QUISPE C, Faria EF, Santos AC, Magnabosco WJ, et al
     Vaginal sparing in laparoscopic radical cystectomy for females: feasibility and technical notes.
     Int Braz J Urol. 2020;46:1109-1110.
     Abstract     Related articles   
     
     
478. TORELLI S, Lenka A, Khan F, Amjad F, et al
     Clinical Reasoning: An 81-year-old woman with confusion, weakness, and left-sided hemineglect.
     Neurology. 2020;95:e3060-e3064.
     Abstract     Related articles   
     
     
479. LIAO W, Zhao W, Wu Y, Rong N, et al
     Multiple metal(loid)s bioaccessibility from cooked seafood and health risk assessment.
     Environ Geochem Health. 2020;42:4037-4050.
     Abstract     Related articles   
     
     
480. SHIGETA K, Hasegawa M, Kikuchi E, Yasumizu Y, et al
     Role of the MUC1-C oncoprotein in the acquisition of cisplatin resistance by urothelial carcinoma.
     Cancer Sci. 2020;111:3639-3652.
     Abstract     Related articles   
     
     
481. HEINSIMER K, Wiegand L
     Transurethral resection of bladder tumor through artificial urinary sphincter.
     Int Braz J Urol. 2020;46:867.
     Abstract     Related articles   
     
     
482. KOGUCHI D, Matsumoto K, Ikeda M, Taoka Y, et al
     Prognostic impact of preoperative renal function in patients treated with radical cystectomy: a multi-institutional retrospective study.
     Int J Clin Oncol. 2020;25:1969-1976.
     Abstract     Related articles   
     
     
483. SI Y, Li L, He B, Li J, et al
     A novel surface-enhanced Raman scattering-based ratiometric approach for detection of hyaluronidase in urine.
     Talanta. 2020;215:120915.
     Abstract     Related articles   
     
     
484. BAEK SW, Jang IH, Kim SK, Nam JK, et al
     Transcriptional Profiling of Advanced Urothelial Cancer Predicts Prognosis and Response to Immunotherapy.
     Int J Mol Sci. 2020;21.
     Abstract     Related articles   
     
     
485. KAMAT AM, Shore N, Hahn N, Alanee S, et al
     KEYNOTE-676: Phase III study of BCG and pembrolizumab for persistent/recurrent high-risk NMIBC.
     Future Oncol. 2020;16:507-516.
     Abstract     Related articles   
     
     
486. LEE SW, Baek SM, Lee AR, Kim TU, et al
     Malignant Peripheral Nerve Sheath Tumour in the Urinary Bladder of a Dog.
     J Comp Pathol. 2020;175:64-68.
     Abstract     Related articles   
     
     
487. ZHU S, He L, Zheng C, Hou Y, et al
     Bladder mulberry-like fibroepithelial polyp with calcification and squamous cell metaplasia mimicking bladder carcinoma: case report and literature review.
     J Int Med Res. 2020;48:300060519896911.
     Abstract     Related articles   
     
     
488. WANG H, Qiao Y, Liu J, Jiang B, et al
     Experimental study of the difference in deformation between normal and pathological, renal and bladder, cells induced by acoustic radiation force.
     Eur Biophys J. 2020;49:155-161.
     Abstract     Related articles   
     
     
489. SHIM JS, Kwon TG, Rha KH, Lee YG, et al
     Do patients benefit from total intracorporeal robotic radical cystectomy?: A comparative analysis with extracorporeal robotic radical cystectomy from a Korean multicenter study.
     Investig Clin Urol. 2020;61:11-18.
     Abstract     Related articles   
     
     
490. ZHANG S, Lin T, Zhang Q, Zhang S, et al
     Comparison of perioperative outcomes in robot-assisted radical cystectomy and laparoscopic radical cystectomy.
     Int J Med Robot. 2020;16:e2074.
     Abstract     Related articles   
     
     
491. FUKUHARA H, Kurabayashi A, Furihata M, Setuda S, et al
     5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence ureterorenoscopy for urinary upper tract urothelial carcinoma approximately Preliminary prospective single centre trial approximately .
     Photodiagnosis Photodyn Ther. 2020;29:101617.
     Abstract     Related articles   
     
     
492. HASSAN O, Murati Amador B, Lombardo KA, Salles D, et al
     Clinical significance of urothelial carcinoma ambiguous for muscularis propria invasion on initial transurethral resection of bladder tumor.
     World J Urol. 2020;38:389-395.
     Abstract     Related articles   
     
     
493. LIN X, Deng T, Wu S, Lin SX, et al
     The clinicopathological characteristics and prognostic value of squamous differentiation in patients with bladder urothelial carcinoma: a meta-analysis.
     World J Urol. 2020;38:323-333.
     Abstract     Related articles   
     
     
494. DONG L, Qin Y, Ya L, Liang C, et al
     Bayesian network analysis of open, laparoscopic, and robot-assisted radical cystectomy for bladder cancer.
     Medicine (Baltimore). 2020;99:e23645.
     Abstract     Related articles   
     
     
495. LI Y, Duan Q, Gan L, Li W, et al
     microRNA-27b inhibits cell proliferation and invasion in bladder cancer by targeting engrailed-2.
     Biosci Rep. 2020 Dec 22. pii: 227414. doi: 10.1042/BSR20201000.
     Abstract     Related articles   
     
     
496. MACCAGNANO C, Rocchini L, Montanari E, Conti GN, et al
     Overview of the italian experience in surgical management of bladder cancer during first month of COVID-19 pandemic.
     Arch Ital Urol Androl. 2020;92.
     Abstract     Related articles   
     
     
497. HUANG Y, Zhang Z, Miao M, Kong C, et al
     The intracellular domain of UNC5B facilities proliferation and metastasis of bladder cancer cells.
     J Cell Mol Med. 2020 Dec 20. doi: 10.1111/jcmm.16172.
     Abstract     Related articles   
     
     
498. WANG X, Zhang R, Wu S, Shen L, et al
     Super-Enhancer LncRNA LINC00162 Promotes Progression of Bladder Cancer.
     iScience. 2020;23:101857.
     Abstract     Related articles   
     
     
499. PENG L, Li J, Meng C, Li J, et al
     Diagnostic Value of Telomerase Activity in Patients With Bladder Cancer: A Meta-Analysis of Diagnostic Test.
     Front Oncol. 2020;10:570127.
     Abstract     Related articles   
     
     
500. WANG Z, Shang J, Li Z, Li H, et al
     PIK3CA Is Regulated by CUX1, Promotes Cell Growth and Metastasis in Bladder Cancer via Activating Epithelial-Mesenchymal Transition.
     Front Oncol. 2020;10:536072.
     Abstract     Related articles   
     
     
501. SZYMANSKA B, Sawicka E, Matuszewski M, Dembowski J, et al
     The Dependence between Urinary Levels of Angiogenesis Factors, 8-Iso-prostaglandin F2alpha, -Synuclein, and Interleukin-13 in Patients with Bladder Cancer: A Pilot Study.
     J Oncol. 2020;2020:4848752.
     Abstract     Related articles   
     
     
502. MASOOD B, Iqbal W, Iqbal N, Hussain I, et al
     Incidental Findings Of Polypoid Cystitis In A 6-Year Old Child Without Any History Of Lower Urinary Tract Symptoms And Previous Urinary Catheterization.
     J Ayub Med Coll Abbottabad. 2020;32:410-412.
     Abstract     Related articles   
     
     
503. WESTERMAN ME, Kokorovic A, Wang XS, Lim A, et al
     Radical Cystectomy and Perioperative Sexual Function: A Cross-Sectional Analysis.
     J Sex Med. 2020;17:1995-2004.
     Abstract     Related articles   
     
     
504. BOETTGE KR, Paasch C, Schrader M, Strik M, et al
     Adenocarcinoma of an ileal conduit developing 8 years after cystoprostatectomy for locally advanced prostate carcinoma.
     BMJ Case Rep. 2020;13.
     Abstract     Related articles   
     
     
505. GUPTA N, Kucirka LM, Semerjian A, Wainger J, et al
     Comparing Provider-Led Sexual Health Counseling of Male and Female Patients Undergoing Radical Cystectomy.
     J Sex Med. 2020;17:949-956.
     Abstract     Related articles   
     
     
506. MAJEWSKI W, Nieckula J, Dworzecki T, Miszczyk L, et al
     Bladder-conserving Approach in Radical Treatment of Patients With Bladder Cancer - A Single-institution Experience.
     Anticancer Res. 2020;40:5861-5868.
     Abstract     Related articles   
     
     
507. PAN Y, Chiu YH, Chiu SC, Cho DY, et al
     Inhibition of Bruton's Tyrosine Kinase Suppresses Cancer Stemness and Promotes Carboplatin-induced Cytotoxicity Against Bladder Cancer Cells.
     Anticancer Res. 2020;40:6093-6099.
     Abstract     Related articles   
     
     
508. SUN YU, Nishino H, Sugisawa N, Yamamoto J, et al
     Oral Recombinant Methioninase Sensitizes a Bladder Cancer Orthotopic Xenograft Mouse Model to Low-dose Cisplatinum and Prevents Metastasis.
     Anticancer Res. 2020;40:6083-6091.
     Abstract     Related articles   
     
     
509. ADELMANN TG, Camerota TC, Ceausu AR, Cimpean AM, et al
     Chloride Intracellular Channel Protein 1 (CLIC1) Iotas Over-expressed in Muscle Invasive Urinary Bladder Cancer.
     Anticancer Res. 2020;40:6879-6884.
     Abstract     Related articles   
     
     
510. LENFANT L, Cancel-Tassin G, Gazut S, Comperat E, et al
     Genetic variability in 13q33 and 9q34 is linked to Aggressiveness Patterns and a Higher risk of progression of Non-Muscle-Invasive Bladder Cancer at the time of Diagnosis.
     BJU Int. 2020 Sep 25. doi: 10.1111/bju.15254.
     Abstract     Related articles   
     
     
511. KARDOUST PARIZI M, Shariat SF, Margulis V, Mori K, et al
     Tumor infiltrating immune cells to predict response to intravesical BCG in Patients with Non-muscle invasive Bladder Cancer: A Systematic Review and meta-analysis.
     BJU Int. 2020 Oct 18. doi: 10.1111/bju.15276.
     Abstract     Related articles   
     
     
512. SPENCER-BOWDAGE S, Russell B, Rigby J, O'Kelly J, et al
     The experience of UK bladder cancer patients during the COVID-19 pandemic: A survey-based snapshot.
     BJU Int. 2020 Oct 30. doi: 10.1111/bju.15287.
     Abstract     Related articles   
     
     
513. SORIA F, Black PC, Fairey AS, Cookson MS, et al
     Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis.
     BJU Int. 2020 Nov 5. doi: 10.1111/bju.15289.
     Abstract     Related articles   
     
     
514. BROOKS NA, Kokorovic A, Xiao L, Matulay JT, et al
     The Obesity Paradox: Defining the impact of Body Mass Index and Diabetes Mellitus for patients with Non-Muscle Invasive Bladder Cancer Treated with Bacillus Calmette-Guerin.
     BJU Int. 2020 Nov 14. doi: 10.1111/bju.15296.
     Abstract     Related articles   
     
     
515. HUSSEIN AA, Elsayed AS, Aldhaam NA, Jing Z, et al
     A comparative propensity score-matched analysis of perioperative outcomes of intracorporeal vs extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.
     BJU Int. 2020;126:265-272.
     Abstract     Related articles   
     
     
516. BENGTSEN MB, Veres K, Norgaard M
     First-time postmenopausal bleeding as a clinical marker of long-term cancer risk: A Danish Nationwide Cohort Study.
     Br J Cancer. 2019 Dec 6. pii: 10.1038/s41416-019-0668.
     Abstract     Related articles   
     
     
517. GARG T, McMullen CK, Leo MC, O'Keeffe-Rosetti MC, et al
     Predicting risk of multiple levels of recurrence and progression after initial diagnosis of nonmuscle-invasive bladder cancer in a multisite, community-based cohort.
     Cancer. 2020 Nov 4. doi: 10.1002/cncr.33300.
     Abstract     Related articles   
     
     
518. BUI NHB, Napoli M, Davis AJ, Abbas HA, et al
     Spatiotemporal Regulation of DeltaNp63 by TGFbeta-Regulated miRNAs Is Essential for Cancer Metastasis.
     Cancer Res. 2020;80:2833-2847.
     Abstract     Related articles   
     
     
519. DOMINGUEZ GUTIERREZ PR, Kwenda EP, Donelan W, O'Malley P, et al
     Hyal2 expression in tumor-associated myeloid cells mediates cancer-related inflammation in bladder cancer.
     Cancer Res. 2020 Nov 25. pii: 0008-5472.CAN-20-1144.
     Abstract     Related articles   
     
     
520. KIKUCHI H, Maishi N, Annan DA, Alam MT, et al
     Chemotherapy-Induced IL8 Upregulates MDR1/ABCB1 in Tumor Blood Vessels and Results in Unfavorable Outcome.
     Cancer Res. 2020;80:2996-3008.
     Abstract     Related articles   
     
     
521. SHARMA P, Sohn J, Shin SJ, Oh DY, et al
     Efficacy and Tolerability of Tremelimumab in Locally Advanced or Metastatic Urothelial Carcinoma Patients Who Have Failed First-Line Platinum-Based Chemotherapy.
     Clin Cancer Res. 2020;26:61-70.
     Abstract     Related articles   
     
     
522. SARI MOTLAGH R, Mori K, Aydh A, Karakiewicz PI, et al
     Impact of hospital and surgeon volumes on short-term and long-term outcomes of radical cystectomy.
     Curr Opin Urol. 2020;30:701-710.
     Abstract     Related articles   
     
     
523. REBHAN K, Ertl IE, Shariat SF, Grollman AP, et al
     Aristolochic acid and its effect on different cancers in uro-oncology.
     Curr Opin Urol. 2020;30:689-695.
     Abstract     Related articles   
     
     
524. ERTL IE, Shariat SF, Mostafaei H, Ilijazi D, et al
     Fibroblast growth factor receptors across urothelial carcinoma landscape.
     Curr Opin Urol. 2020;30:557-565.
     Abstract     Related articles   
     
     
525. BRONIMANN S, Lemberger U, Bruchbacher A, Shariat SF, et al
     Poly(ADP-ribose) polymerase inhibitors in prostate and urothelial cancer.
     Curr Opin Urol. 2020;30:519-526.
     Abstract     Related articles   
     
     
526. LIU B, Welk B
     Urological malignancies in neurogenic patients.
     Curr Opin Urol. 2020;30:501-506.
     Abstract     Related articles   
     
     
527. PRADERE B, Schuettfort V, Mori K, Quhal F, et al
     Management of de-novo urothelial carcinoma in transplanted patients.
     Curr Opin Urol. 2020;30:467-474.
     Abstract     Related articles   
     
     
528. JAHRREISS V, Pradere B, Laukhtina E, Mori K, et al
     Catalog of exogenous risk factors for bladder carcinogenesis.
     Curr Opin Urol. 2020;30:449-456.
     Abstract     Related articles   
     
     
529. CARANDO R, Shariat SF, Moschini M, D'Andrea D, et al
     Ureteral and urethral recurrence after radical cystectomy: a systematic review.
     Curr Opin Urol. 2020;30:441-448.
     Abstract     Related articles   
     
     
530. KHETRAPAL P, Conroy S, Kelly JD, Catto JWF, et al
     Comparing open-radical cystectomy and robot-assisted radical cystectomy: current status and analysis of the evidence.
     Curr Opin Urol. 2020;30:400-406.
     Abstract     Related articles   
     
     
531. SUBIELA JD, Rodriguez Faba O, Guerrero-Ramos F, Aumatell J, et al
     Carcinoma in situ of the bladder: why is it underdetected?
     Curr Opin Urol. 2020;30:392-399.
     Abstract     Related articles   
     
     
532. SORIA F, Giordano A, Gontero P
     Transurethral resection of bladder tumor and the need for re-transurethral resection of bladder tumor: time to change our practice?
     Curr Opin Urol. 2020;30:370-376.
     Abstract     Related articles   
     
     
533. TERRITO A, Bevilacqua G, Meneghetti I, Mercade A, et al
     En bloc resection of bladder tumors: indications, techniques, and future directions.
     Curr Opin Urol. 2020;30:421-427.
     Abstract     Related articles   
     
     
534. LOTAN Y
     Novel technologies that change the diagnostic and treatment paradigm in urology: standard turbt remains the standard.
     Curr Opin Urol. 2020;30:477-478.
     Abstract     Related articles   
     
     
535. ALMASSI N, Bochner BH
     Ileal conduit or orthotopic neobladder: selection and contemporary patterns of use.
     Curr Opin Urol. 2020;30:415-420.
     Abstract     Related articles   
     
     
536. MATSUMOTO S, Kijima T, Matsuoka Y, Yamamoto M, et al
     A case of recurrent thrombocytopenia involving divergent immune-related mechanisms associated with pembrolizumab.
     Eur J Cancer. 2020;131:104-107.
     Abstract     Related articles   
     
     
537. LIEDBERG F, Eriksson P, Sjodahl G
     Re: A. Gordon Robertson, Clarice S. Groeneveld, Brian Jordan, et al. Identification of Differential Tumor Subtypes of T1 Bladder Cancer. Eur Urol. In press. http://doi.org/10.1016/j.eururo.2020.06.048.
     Eur Urol. 2020 Sep 28. pii: S0302-2838(20)30708.
     Abstract     Related articles   
     
     
538. MEEKS JJ, Dyrsjkot L, Robertson AG
     Reply to Fredrik Liedberg, Pontus Eriksson, and Gottfrid Sjodahl's Letter to the Editor re: A. Gordon Robertson, Clarice S. Groeneveld, Brian Jordan, et al. Identification of Differential Tumor Subtypes of T1 Bladder Cancer. Eur Urol. In press. http:/
     Eur Urol. 2020 Sep 26. pii: S0302-2838(20)30722.
     Abstract     Related articles   
     
     
539. PACKIAM VT, Bhindi B
     Are We Moving Closer to Accurate Restaging after Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer?
     Eur Urol. 2020 Sep 23. pii: S0302-2838(20)30711.
     Abstract     Related articles   
     
     
540. TEOH JY, Huang J, Ko WY, Lok V, et al
     Global Trends of Bladder Cancer Incidence and Mortality, and Their Associations with Tobacco Use and Gross Domestic Product Per Capita.
     Eur Urol. 2020 Sep 21. pii: S0302-2838(20)30697.
     Abstract     Related articles   
     
     
541. RIAZ IB, Hussain SA
     Perioperative Treatment in Muscle-invasive Bladder Cancer: Analysis of Secondary Endpoints in a Randomized Trial Comparing Gemcitabine and Cisplatin Versus Dose-dense Methotrexate, Vinblastine, Adriamycin, and Cisplatin.
     Eur Urol. 2020 Oct 1. pii: S0302-2838(20)30710.
     Abstract     Related articles   
     
     
542. LOEB S, Reines K, Abu-Salha Y, French W, et al
     Quality of Bladder Cancer Information on YouTube.
     Eur Urol. 2020 Sep 30. pii: S0302-2838(20)30706.
     Abstract     Related articles   
     
     
543. MITRA AP, Miest T, Dinney CPN
     Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non-Muscle-Invasive Bladder Cancer.
     Eur Urol. 2020 Nov 3. pii: S0302-2838(20)30809.
     Abstract     Related articles   
     
     
544. IYER G, Bochner BH, Van Allen EM, Solit DB, et al
     Re: Russell E.N. Becker, Alexa R. Meyer, Aaron Brant, et al. Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eu
     Eur Urol. 2020 Nov 17. pii: S0302-2838(20)30865.
     Abstract     Related articles   
     
     
545. BECKER REN, Baras A, Bivalacqua TJ
     Reply to Gopa Iyer, Bernard H. Bochner, Eliezer M. Van Allen, David B. Solit, and Jonathan E. Rosenberg's Letter to the Editor re: Russell E.N. Becker, Alexa R. Meyer, Aaron Brant, et al. Clinical Restaging and Tumor Sequencing are Inaccurate Indicato
     Eur Urol. 2020 Nov 17. pii: S0302-2838(20)30864.
     Abstract     Related articles   
     
     
546. BAKER SC, Mason AS, Southgate J
     Does a Novel Mutagenic Process Target KMT2D Mutation in the Most Common First Event on the Path to Bladder Cancer?
     Eur Urol. 2020 Nov 14. pii: S0302-2838(20)30866.
     Abstract     Related articles   
     
     
547. PANEBIANCO V, Del Giudice F, Narumi Y, Simone G, et al
     Re: Helena Vila-Reyes, G. Joel DeCastro, and James M. McKiernan's Letter to the Editor re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imag
     Eur Urol. 2020 Nov 28. pii: S0302-2838(20)30861.
     Abstract     Related articles   
     
     
548. VILA-REYES H, Joel DeCastro G, McKiernan JM
     Reply to Valeria Panebianco, Francesco Del Giudice, Yoshifumi Narumi, Giuseppe Simone, Ettore De Berardinis, and James Catto's Letter to the Editor re: Helena Vila-Reyes, G. Joel De Castro, and James M. McKiernan's Letter to the Editor re: Yunjin Bai,
     Eur Urol. 2020 Nov 25. pii: S0302-2838(20)30883.
     Abstract     Related articles   
     
     
549. MEEKS JJ, Robertson AG
     Immune Signatures Dominate Molecular Subtyping to Predict Response to Neoadjuvant Immunotherapy.
     Eur Urol. 2020;77:711-712.
     Abstract     Related articles   
     
     
550. BABJUK M
     Are the Role of Surgery and its Complications Sufficiently Focused in the Era of Perioperative Systemic Treatments?
     Eur Urol. 2020;77:581-582.
     Abstract     Related articles   
     
     
551. MANTICA G, Terrone C
     Re: Eugene Shkolyar, Xiao Jia, Timothy C. Chang, et al. Augmented Bladder Tumor Detection Using Deep Learning. Eur Urol 2019;76:714-8.
     Eur Urol. 2020;77:e133.
     Abstract     Related articles   
     
     
552. HUSSAIN SA, Porta N, Hall E, Salawu A, et al
     Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by (Chemo)radiotherapy in the BC2001 Trial.
     Eur Urol. 2020 Dec 5. pii: S0302-2838(20)30937.
     Abstract     Related articles   
     
     
553. DE VERE WHITE R, Dall'Era M
     Re: Quality Indicators for Bladder Cancer Services: A Collaborative Review.
     Eur Urol. 2020 Dec 5. pii: S0302-2838(20)30932.
     Abstract     Related articles   
     
     
554. MANTICA G, Terrone C, Der Merwe AV
     Bladder Cancer and Associated Risk Factors: The African Panorama.
     Eur Urol. 2020 Dec 3. pii: S0302-2838(20)30942.
     Abstract     Related articles   
     
     
555. POLETAJEW S, Krajewski W, Zdrojowy R, Kryst P, et al
     Re: Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme.
     Eur Urol. 2020 Dec 10. pii: S0302-2838(20)30928.
     Abstract     Related articles   
     
     
556. MONTORSI F, Bandini M, Necchi A
     Re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive
     Eur Urol. 2020;78:e75-e76.
     Abstract     Related articles   
     
     
557. WIECZOREK E, Garstka MA
     Recurrent Bladder Cancer in Aging Societies: Importance of Major Histocompatibility Complex Class I Antigen Presentation.
     Int J Cancer. 2020 Oct 26. doi: 10.1002/ijc.33359.
     Abstract     Related articles   
     
     
558. OZGUN G, Senturk S, Erkek-Ozhan S
     Retinoic acid signaling and bladder cancer: Epigenetic deregulation, therapy and beyond.
     Int J Cancer. 2020 Oct 31. doi: 10.1002/ijc.33374.
     Abstract     Related articles   
     
     
559. TAOKA R, Matsuoka Y, Kohashiguchi K, Miura T, et al
     Impact of second transurethral resection on recurrence in patients with high-grade Ta bladder cancer.
     Int J Urol. 2020 Sep 28. doi: 10.1111/iju.14372.
     Abstract     Related articles   
     
     
560. NAKAGAWA T
     Lymph node dissection for bladder cancer: Current standards and the latest evidence.
     Int J Urol. 2020 Nov 3. doi: 10.1111/iju.14398.
     Abstract     Related articles   
     
     
561. TANAKA H, Fujii Y
     Editorial Comment to Lymph node dissection for bladder cancer: Current standards and the latest evidence.
     Int J Urol. 2020 Nov 3. doi: 10.1111/iju.14419.
     Abstract     Related articles   
     
     
562. ZHONG H, Shen Y, Yao Z, Chen X, et al
     Long-term outcome of spiral ileal neobladder with orthotopic ureteral reimplantation.
     Int Urol Nephrol. 2020;52:41-49.
     Abstract     Related articles   
     
     
563. CATTO JWF, Gordon K, Collinson M, Poad H, et al
     Radical Cystectomy Against Intravesical BCG for High-Risk High-Grade Nonmuscle Invasive Bladder Cancer: Results From the Randomized Controlled BRAVO-Feasibility Study.
     J Clin Oncol. 2020 Dec 17:JCO2001665. doi: 10.1200/JCO.20.01665.
     Abstract     Related articles   
     
     
564. LAVIANA AA, Stone BV, Avulova S
     Editorial Comment.
     J Urol. 2020;204:458-459.
     Abstract     Related articles   
     
     
565. KRETSCHMER A
     Editorial Comment.
     J Urol. 2020;204:458.
     Abstract     Related articles   
     
     
566. CHANG SS
     Editorial Comment.
     J Urol. 2020;204:449.
     Abstract     Related articles   
     
     
567. CADEDDU JA
     Re: Long-Term Oncological Outcomes from an Early Phase Randomised Controlled Three-Arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL).
     J Urol. 2020;204:598.
     Abstract     Related articles   
     
     
568. MYRIE AK, Matulewicz RS
     Perceptions of the Link Between Smoking and Bladder Cancer Among United States Adults.
     J Urol. 2020 Oct 14:101097JU0000000000001415. doi: 10.1097/JU.0000000000001415.
     Abstract     Related articles   
     
     
569. YIN G, Tang J, Wang L
     Re: A Urine Based Genomic Assay to Triage Patients with Hematuria for CystoscopyK. E. M. van Kessel, J. J. de Jong, A. C. J. Ziel-van der Made, H. Roshani, S. M. Haensel, J. H. Wolterbeek, E. R. Boeve, E. H. G. M. Oomens, N. J. van Casteren, M. Krispi
     J Urol. 2020;204:1062.
     Abstract     Related articles   
     
     
570. DASON S, Cha EK, Falavolti C, Vertosick EA, et al
     Late Recurrences Following Radical Cystectomy Have Distinct Prognostic and Management Considerations.
     J Urol. 2020;204:460-465.
     Abstract     Related articles   
     
     
571. SCHMIDT A, Warmann SW, Eckert F, Ellerkamp V, et al
     The Role of Reconstructive Surgery and Brachytherapy in Pediatric Bladder/Prostate Rhabdomyosarcoma.
     J Urol. 2020;204:825-834.
     Abstract     Related articles   
     
     
572. ALMASSI N, Cha EK, Vertosick EA, Huang C, et al
     Trends in Management and Outcomes among Patients with Urothelial Carcinoma Undergoing Radical Cystectomy from 1995 to 2015: The Memorial Sloan Kettering Experience.
     J Urol. 2020;204:677-684.
     Abstract     Related articles   
     
     
573. CACCIAMANI GE, Ghodoussipour S, Mari A, Gill KS, et al
     Association between Smoking Exposure, Neoadjuvant Chemotherapy Response and Survival Outcomes following Radical Cystectomy: Systematic Review and Meta-Analysis.
     J Urol. 2020;204:649-660.
     Abstract     Related articles   
     
     
574. HANNA PT, Peterson M, Albersheim J, Drawz P, et al
     Acute Kidney Injury following Enhanced Recovery after Surgery in Patients Undergoing Radical Cystectomy.
     J Urol. 2020;204:982-988.
     Abstract     Related articles   
     
     
575. DE JONG FC, Hoedemaeker RF, Kvikstad V, Mensink JTM, et al
     T1-Substaging of Non-muscle Invasive Bladder Cancer is Associated with BCG-Failure and Improves Patient Stratification at Diagnosis.
     J Urol. 2020 Nov 16:101097JU0000000000001422. doi: 10.1097/JU.0000000000001422.
     Abstract     Related articles   
     
     
576. CHANG SS
     Re: Impact of Adjuvant Chemotherapy in Patients with Adverse Features and Variant Histology at Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder: Does Histologic Subtype Matter?
     J Urol. 2020;204:1378.
     Abstract     Related articles   
     
     
577. WANG DS
     Re: Epidural Anesthesia is Associated with Increased Complications in Cystectomy Patients: A NSQIP Analysis.
     J Urol. 2020;204:1072-1073.
     Abstract     Related articles   
     
     
578. MORI K, Abufaraj M, Mostafaei H, Quhal F, et al
     A Systematic Review and Meta-Analysis of Variant Histology in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy.
     J Urol. 2020;204:1129-1140.
     Abstract     Related articles   
     
     
579. ROSE M, Maurer A, Wirtz J, Bleilevens A, et al
     EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancer.
     Oncogene. 2020 Sep 25. pii: 10.1038/s41388-020-01465.
     Abstract     Related articles   
     
     
580. JIN Y, Zhou Y, Deng W, Wang Y, et al
     Genome-wide profiling of BK polyomavirus integration in bladder cancer of kidney transplant recipients reveals mechanisms of the integration at the nucleotide level.
     Oncogene. 2020 Oct 13. pii: 10.1038/s41388-020-01502.
     Abstract     Related articles   
     
     
581. JIA Y, Ding X, Zhou L, Zhang L, et al
     Mesenchymal stem cells-derived exosomal microRNA-139-5p restrains tumorigenesis in bladder cancer by targeting PRC1.
     Oncogene. 2020 Oct 29. pii: 10.1038/s41388-020-01486.
     Abstract     Related articles   
     
     
582. ROSE M, Maurer A, Wirtz J, Bleilevens A, et al
     Correction: EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancer.
     Oncogene. 2020 Dec 1. pii: 10.1038/s41388-020-01534.
     Abstract     Related articles   
     
     
583. SHEN C, Wang Y, Wu Z, Da, et al
     Long noncoding RNAs, ENST00000598996 and ENST00000524265, are correlated with favorable prognosis and act as potential tumor suppressors in bladder cancer.
     Oncol Rep. 2020;44:1831-1850.
     Abstract     Related articles   
     
     
584. CHEN Y, Xu T, Xie F, Wang L, et al
     Evaluating the biological functions of the prognostic genes identified by the Pathology Atlas in bladder cancer.
     Oncol Rep. 2020 Nov 13. doi: 10.3892/or.2020.7853.
     Abstract     Related articles   
     
     
585. ZHANG Z, Chen F, Zhan H, Chen L, et al
     lncRNA CASC9 sponges miR7583p to promote proliferation and EMT in bladder cancer by upregulating TGFbeta2.
     Oncol Rep. 2020 Nov 13. doi: 10.3892/or.2020.7852.
     Abstract     Related articles   
     
     
586. BRANCHU B, Leon P, Jeglinschi SC, Durlach A, et al
     [Interest of reTURB for pTa high grade bladder urothelial carcinoma].
     Prog Urol. 2020;30:19-25.
     Abstract     Related articles   
     
     
587. CERF N, Radulescu C, Neuzillet Y, Rouanne M, et al
     [Usefulness of frozen section exams during radical cystectomy for urothelial carcinoma].
     Prog Urol. 2020;30:51-57.
     Abstract     Related articles   
     
     
588. BIARDEAU X, Lamande N, Tondut L, Peyronnet B, et al
     Quality of life associated with orthotopic neobladder and ileal conduit in women: A multicentric cross-sectional study.
     Prog Urol. 2020;30:80-88.
     Abstract     Related articles   
     
     
589. ROUPRET M, Pignot G, Masson-Lecomte A, Comperat E, et al
     [French ccAFU guidelines - update 2020-2022: bladder cancer].
     Prog Urol. 2020;30.
     Abstract     Related articles   
     
     
590. RABER M, Buchholz N, Vercesi A, Hendawi NA, et al
     Treatment of Large Non-Muscle-Invasive Bladder Cancer: The Potential Role of Neoadjuvant Intravesical Chemotherapy.
     Urol Int. 2020 Dec 17:1-6. doi: 10.1159/000512052.
     Abstract     Related articles   
     
     
591. BAGHERI I, Shan Y, Klaassen Z, Kamat AM, et al
     Comparing Costs of Radical Versus Partial Cystectomy for Patients Diagnosed with Localized Muscle-Invasive Bladder Cancer: Understanding the Value of Surgical Care.
     Urology. 2020 Sep 24. pii: S0090-4295(20)31169.
     Abstract     Related articles   
     
     
592. KOCH GE, Smelser WW, Chang SS
     Side Effects of Intravesical BCG and Chemotherapy for Bladder Cancer: What They Are and How To Manage Them.
     Urology. 2020 Nov 9. pii: S0090-4295(20)31349.
     Abstract     Related articles   
     
     
593. MAGGEN C, Linssen J, Gziri MM, Zola P, et al
     Renal and Bladder Cancer During Pregnancy: A Review of 47 Cases and Literature-based Recommendations for Management.
     Urology. 2020 Oct 22. pii: S0090-4295(20)31271.
     Abstract     Related articles   
     
     
594. KOTECHA P, Moss CL, Enting D, Gillett C, et al
     Cohort profile: King's Health Partners bladder cancer biobank.
     BMC Cancer. 2020;20:920.
     Abstract     Related articles   
     
     
595. LIU B, Sun W, Gao W, Li L, et al
     microRNA-451a promoter methylation regulated by DNMT3B expedites bladder cancer development via the EPHA2/PI3K/AKT axis.
     BMC Cancer. 2020;20:1019.
     Abstract     Related articles   
     
     
596. PARKER HG, Dhawan D, Harris AC, Ramos-Vara JA, et al
     RNAseq expression patterns of canine invasive urothelial carcinoma reveal two distinct tumor clusters and shared regions of dysregulation with human bladder tumors.
     BMC Cancer. 2020;20:251.
     Abstract     Related articles   
     
     
597. ZHAI M, Tang C, Li M, Chen X, et al
     Short-term mortality risks among patients with non-metastatic bladder cancer.
     BMC Cancer. 2020;20:1148.
     Abstract     Related articles   
     
     
598. HUPE MC, Dormayer L, Ozimek T, Struck JP, et al
     Impact of double J stenting or nephrostomy placement during transurethral resection of bladder tumour on the incidence of metachronous upper urinary tract urothelial cancer.
     BMC Cancer. 2020;20:140.
     Abstract     Related articles   
     
     
599. JOHN A, Gunes C, Bolenz C, Vidal-Y-Sy S, et al
     Bladder cancer-derived interleukin-1 converts the vascular endothelium into a pro-inflammatory and pro-coagulatory surface.
     BMC Cancer. 2020;20:1178.
     Abstract     Related articles   
     
     
600. KIM TM, Yoo JS, Moon HW, Hur KJ, et al
     Distinct mutation profiles between primary bladder cancer and circulating tumor cells warrant the use of circulating tumors cells as cellular resource for mutation follow-up.
     BMC Cancer. 2020;20:1203.
     Abstract     Related articles   
     
     
601. REED O, Jubber I, Griffin J, Noon AP, et al
     Occupational bladder cancer: A cross section survey of previous employments, tasks and exposures matched to cancer phenotypes.
     PLoS One. 2020;15:e0239338.
     Abstract     Related articles   
     
     
602. TELEKA S, Hindy G, Drake I, Poveda A, et al
     Blood pressure and bladder cancer risk in men by use of survival analysis and in interaction with NAT2 genotype, and by Mendelian randomization analysis.
     PLoS One. 2020;15:e0241711.
     Abstract     Related articles   
     
     
603. AZUMA T, Sato Y, Ohno T, Azuma M, et al
     Serum soluble B7-H3 is a prognostic marker for patients with non-muscle-invasive bladder cancer.
     PLoS One. 2020;15:e0243379.
     Abstract     Related articles   
     
     
604. 
     Retraction: MicroRNA-214 Suppresses Oncogenesis and Exerts Impact on Prognosis by Targeting PDRG1 in Bladder Cancer.
     PLoS One. 2020;15:e0244274.
     Abstract     Related articles   
     
     
605. KARDOS J, Rose TL, Manocha U, Wobker SE, et al
     Development and validation of a NanoString BASE47 bladder cancer gene classifier.
     PLoS One. 2020;15:e0243935.
     Abstract     Related articles   
     
     
606. BARROWS D, Feng L, Carroll TS, Allis CD, et al
     Loss of UTX/KDM6A and the activation of FGFR3 converge to regulate differentiation gene-expression programs in bladder cancer.
     Proc Natl Acad Sci U S A. 2020 Sep 28. pii: 2008017117.
     Abstract     Related articles